| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.62e-14 | 16 | 132 | 8 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.57e-13 | 21 | 132 | 8 | GO:0030228 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL5A2 VWF COL19A1 LAMA1 LAMA3 LAMC1 TECTA FBLN1 FBN2 EFEMP1 CCN1 SPON1 LTBP1 MUC2 | 1.90e-12 | 188 | 132 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | VLDLR FAT4 DNER CD320 VWCE LRP1B LDLR LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 4.03e-09 | 749 | 132 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | cargo receptor activity | 9.25e-08 | 85 | 132 | 8 | GO:0038024 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 1.12e-06 | 4 | 132 | 3 | GO:0030229 | |
| GeneOntologyMolecularFunction | growth factor binding | 9.41e-06 | 156 | 132 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | reelin receptor activity | 4.34e-05 | 2 | 132 | 2 | GO:0038025 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 8.15e-05 | 35 | 132 | 4 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 8.15e-05 | 35 | 132 | 4 | GO:0071814 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.47e-04 | 120 | 132 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | integrin binding | 1.65e-04 | 175 | 132 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.51e-04 | 85 | 132 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 2.65e-04 | 86 | 132 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL5A2 VWF COL19A1 LAMA1 LAMA3 LAMC1 TECTA FBLN1 FBN2 EFEMP1 CCN1 SPON1 LTBP1 MUC2 NUP153 | 2.67e-04 | 891 | 132 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.96e-04 | 20 | 132 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | fibrinogen binding | 6.39e-04 | 6 | 132 | 2 | GO:0070051 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 6.57e-04 | 26 | 132 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | histone modifying activity | 8.34e-04 | 229 | 132 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 9.10e-04 | 29 | 132 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | growth factor activity | 1.03e-03 | 173 | 132 | 6 | GO:0008083 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.40e-03 | 73 | 132 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.72e-03 | 36 | 132 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 2.16e-03 | 200 | 132 | 6 | GO:0008237 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.26e-03 | 430 | 132 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 2.29e-03 | 11 | 132 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 2.29e-03 | 11 | 132 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | zinc ion binding | USP49 FBXO11 TRIM27 BRAP MMP25 RNF125 SEC24C PRICKLE3 TRIM28 DPF3 UHRF1 PAPPA ALB NUP153 | 2.32e-03 | 891 | 132 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | virus receptor activity | 2.44e-03 | 85 | 132 | 4 | GO:0001618 | |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 2.74e-03 | 12 | 132 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | activin binding | 2.74e-03 | 12 | 132 | 2 | GO:0048185 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.74e-03 | 12 | 132 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 2.74e-03 | 12 | 132 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 3.23e-03 | 13 | 132 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 3.23e-03 | 13 | 132 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 3.48e-03 | 46 | 132 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 3.75e-03 | 14 | 132 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | cytokine binding | 3.92e-03 | 157 | 132 | 5 | GO:0019955 | |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA4F VLDLR LRP12 FAT4 SETX TRIO LAMA1 LMTK2 LAMA3 LAMC1 GRN TECTA EZH2 FAS ADAM10 LRP8 WDR47 EFEMP1 LMX1A OTOGL SLIT1 LRP1 NGFR LRP2 CCR5 MINAR1 TCTN1 NOTCH2 NOTCH3 VEGFA | 2.00e-10 | 1285 | 128 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | SEMA4F VLDLR LRP12 FAT4 SETX TRIO LAMA1 LMTK2 LAMA3 LAMC1 GRN TECTA EZH2 FAS ADAM10 LRP8 WDR47 EFEMP1 TENM4 LMX1A OTOGL SLIT1 LRP1 NGFR LRP2 CCR5 MINAR1 TCTN1 NOTCH2 NOTCH3 VEGFA | 1.00e-09 | 1463 | 128 | 31 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon guidance | SEMA4F TRIO LAMA1 LMTK2 LAMA3 LAMC1 LMX1A SLIT1 LRP1 NGFR LRP2 NOTCH2 NOTCH3 VEGFA | 2.86e-09 | 285 | 128 | 14 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | SEMA4F TRIO LAMA1 LMTK2 LAMA3 LAMC1 LMX1A SLIT1 LRP1 NGFR LRP2 NOTCH2 NOTCH3 VEGFA | 2.99e-09 | 286 | 128 | 14 | GO:0097485 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SEMA4F VLDLR TRIO LAMA1 LMTK2 LAMA3 LAMC1 TECTA ADAM10 LRP8 WDR47 LMX1A SLIT1 LRP1 NGFR LRP2 CCR5 TCTN1 NOTCH2 NOTCH3 VEGFA | 6.77e-09 | 748 | 128 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | artery development | 1.05e-08 | 133 | 128 | 10 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | COL3A1 PCSK5 VWC2 VWF DEFB118 LAMC1 ITGA2B TECTA ITGB6 SNED1 FBLN1 CSF1 CCN1 LRP1 VEGFA | 3.96e-08 | 410 | 128 | 15 | GO:0031589 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | VEGFC COL3A1 VWC2 FAT4 SETX CHRDL2 CRIM1 LMTK2 ITGB6 LRP8 TGFBR2 FBN2 CCN1 LRP1 NGFR LRP2 LTBP1 TWSG1 FST NOTCH2 VEGFA | 6.10e-08 | 850 | 128 | 21 | GO:0071363 |
| GeneOntologyBiologicalProcess | axonogenesis | SEMA4F TRIO LAMA1 LMTK2 LAMA3 LAMC1 WDR47 LMX1A SLIT1 LRP1 NGFR LRP2 CCR5 TCTN1 NOTCH2 NOTCH3 VEGFA | 8.20e-08 | 566 | 128 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | gliogenesis | VEGFC COL3A1 DNER GRN EZH2 FAS LDLR LRP8 WDR47 EFEMP1 TENM4 CSF1 LRP1 LRP2 NOTCH2 | 8.59e-08 | 435 | 128 | 15 | GO:0042063 |
| GeneOntologyBiologicalProcess | axon development | SEMA4F TRIO LAMA1 LMTK2 LAMA3 LAMC1 GRN WDR47 LMX1A SLIT1 LRP1 NGFR LRP2 CCR5 TCTN1 NOTCH2 NOTCH3 VEGFA | 9.27e-08 | 642 | 128 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SEMA4F VLDLR TRIO LAMA1 LMTK2 LAMA3 LAMC1 ADAM10 LRP8 WDR47 LMX1A SLIT1 LRP1 NGFR LRP2 CCR5 TCTN1 NOTCH2 NOTCH3 VEGFA | 1.13e-07 | 802 | 128 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | response to growth factor | VEGFC COL3A1 VWC2 FAT4 SETX CHRDL2 CRIM1 LMTK2 ITGB6 LRP8 TGFBR2 FBN2 CCN1 LRP1 NGFR LRP2 LTBP1 TWSG1 FST NOTCH2 VEGFA | 1.16e-07 | 883 | 128 | 21 | GO:0070848 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SEMA4F VLDLR TRIO LAMA1 LMTK2 LAMA3 LAMC1 ADAM10 LRP8 WDR47 LMX1A SLIT1 LRP1 NGFR LRP2 CCR5 TCTN1 NOTCH2 NOTCH3 VEGFA | 1.58e-07 | 819 | 128 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SEMA4F VLDLR TRIO LAMA1 LMTK2 LAMA3 LAMC1 ADAM10 LRP8 WDR47 LMX1A SLIT1 LRP1 NGFR LRP2 CCR5 TCTN1 NOTCH2 NOTCH3 VEGFA | 1.81e-07 | 826 | 128 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | VEGFC COL3A1 VWC2 FAT4 SETX CHRDL2 CRIM1 TRIO LMTK2 ITGB6 TGFBR2 FBN2 EFEMP1 CSF1 CCN1 LRP1 NGFR LRP2 ROS1 LTBP1 TWSG1 FST NOTCH2 VEGFA | 2.57e-07 | 1186 | 128 | 24 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | VEGFC VWC2 CHRDL2 CRIM1 FBN2 CCN1 LRP1 NGFR LRP2 LTBP1 TWSG1 FST NOTCH2 VEGFA | 2.84e-07 | 412 | 128 | 14 | GO:0090287 |
| GeneOntologyBiologicalProcess | vasculature development | VEGFC COL3A1 PCSK5 LAMA1 GRN ITGA2B ADAM12 ADAM10 LDLR TGFBR2 GLA CCN1 BRPF1 LRP1 NGFR LRP2 MINAR1 LTBP1 NOTCH2 NOTCH3 VEGFA | 5.36e-07 | 969 | 128 | 21 | GO:0001944 |
| GeneOntologyBiologicalProcess | embryo development | VEGFC COL3A1 PCSK5 COL5A2 LAMA1 LAMA3 SLC34A2 GRN TECTA ADAM10 LRP1B TGFBR2 KMT2D FBN2 TENM4 SEC24C CCN1 TRIM28 CCDC62 BRPF1 LRP2 PDS5A TWSG1 TCTN1 NOTCH2 VEGFA | 6.50e-07 | 1437 | 128 | 26 | GO:0009790 |
| GeneOntologyBiologicalProcess | glial cell migration | 6.55e-07 | 80 | 128 | 7 | GO:0008347 | |
| GeneOntologyBiologicalProcess | aorta development | 6.55e-07 | 80 | 128 | 7 | GO:0035904 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | COL3A1 VWC2 CHRDL2 CRIM1 ITGB6 TGFBR2 FBN2 CCN1 LRP1 LRP2 LTBP1 TWSG1 FST NOTCH2 | 7.16e-07 | 445 | 128 | 14 | GO:0141091 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | VEGFC COL3A1 COL5A2 FAT4 ABCA12 LAMA1 LAMA3 LAMC1 TECTA ITGB6 FEM1B TGFBR2 FBN2 CSF1 CCN1 SLIT1 NGFR LRP2 PDS5A TWSG1 FST USH2A NOTCH2 VEGFA | 8.69e-07 | 1269 | 128 | 24 | GO:0009887 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | VEGFC COL3A1 FAT4 LAMA1 LAMC1 FEM1B TGFBR2 CSF1 CCN1 TRIM28 BRPF1 NGFR LRP2 TWSG1 FST TCTN1 NOTCH2 VEGFA | 9.02e-07 | 750 | 128 | 18 | GO:0048729 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.06e-06 | 124 | 128 | 8 | GO:0007229 | |
| GeneOntologyBiologicalProcess | blood vessel development | VEGFC COL3A1 PCSK5 LAMA1 GRN ITGA2B ADAM12 LDLR TGFBR2 GLA CCN1 BRPF1 LRP1 NGFR LRP2 MINAR1 LTBP1 NOTCH2 NOTCH3 VEGFA | 1.15e-06 | 929 | 128 | 20 | GO:0001568 |
| GeneOntologyBiologicalProcess | skeletal system development | COL3A1 PCSK5 COL5A2 FAT4 CHRDL2 COL19A1 ITGB6 TGFBR2 FBN2 EFEMP1 CCN1 PDS5A TWSG1 FST NOTCH2 VEGFA | 1.36e-06 | 615 | 128 | 16 | GO:0001501 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | VEGFC FAT4 LAMA1 LAMC1 FEM1B TGFBR2 CSF1 CCN1 TRIM28 BRPF1 NGFR LRP2 FST TCTN1 NOTCH2 VEGFA | 1.48e-06 | 619 | 128 | 16 | GO:0002009 |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.61e-06 | 131 | 128 | 8 | GO:0030510 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.70e-06 | 92 | 128 | 7 | GO:0048844 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | VWC2 CHRDL2 CRIM1 TGFBR2 FBN2 CCN1 LRP1 LRP2 LTBP1 TWSG1 FST NOTCH2 | 1.76e-06 | 347 | 128 | 12 | GO:0090092 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | COL3A1 VWC2 CHRDL2 CRIM1 ITGB6 TGFBR2 FBN2 CCN1 LRP1 LRP2 LTBP1 TWSG1 FST NOTCH2 | 1.83e-06 | 482 | 128 | 14 | GO:0007178 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 2.31e-06 | 5 | 128 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | circulatory system development | AKAP6 VEGFC COL3A1 PCSK5 FAT4 LAMA1 GRN ITGA2B ADAM12 ADAM10 LDLR TGFBR2 TENM4 GLA CCN1 BRPF1 LRP1 NGFR LRP2 PDS5A MINAR1 LTBP1 NOTCH2 NOTCH3 VEGFA | 2.40e-06 | 1442 | 128 | 25 | GO:0072359 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA4F VLDLR TRIO LAMA1 LMTK2 LAMA3 LAMC1 TECTA ADAM10 ITGB6 LRP8 WDR47 LMX1A SLIT1 LRP1 NGFR LRP2 CCR5 TCTN1 NOTCH2 NOTCH3 VEGFA | 4.07e-06 | 1194 | 128 | 22 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of cell migration | VEGFC COL3A1 PCSK5 SEMA4F LAMA1 LAMA3 GRN ITGA2B EZH2 FAS ADAM10 TGFBR2 FBLN1 FBN2 EFEMP1 CSF1 CCN1 LRP1 NGFR CCR5 MUC2 VEGFA | 5.10e-06 | 1211 | 128 | 22 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of locomotion | VEGFC COL3A1 PCSK5 SEMA4F LAMA1 LAMA3 GRN ITGA2B EZH2 FAS ADAM10 TGFBR2 FBLN1 FBN2 EFEMP1 CSF1 CCN1 SLIT1 LRP1 NGFR CCR5 MUC2 VEGFA | 6.55e-06 | 1327 | 128 | 23 | GO:0040012 |
| GeneOntologyBiologicalProcess | growth | AKAP6 COL3A1 ATRN SEMA4F LRP12 GRN EZH2 ADAM10 TGFBR2 EYS KMT2D TENM4 CSF1 LMX1A TRIM28 SLIT1 LRP1 ROS1 CCR5 MINAR1 NOTCH2 VEGFA | 6.97e-06 | 1235 | 128 | 22 | GO:0040007 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | COL3A1 PCSK5 DEFB118 ITGA2B TECTA ITGB6 SNED1 CSF1 LRP1 VEGFA | 7.31e-06 | 270 | 128 | 10 | GO:0007160 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | VEGFC SEMA4F COL5A2 CRIM1 TRIO CCND1 EZH2 FAS LDLR EFEMP1 LMX1A SLIT1 CCR5 TWSG1 FST USH2A NOTCH3 VEGFA | 7.79e-06 | 875 | 128 | 18 | GO:0045596 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | VEGFC SEMA4F LRRN1 EZH2 FAS LDLR LRP8 TENM4 SLIT1 LRP1 NGFR LRP2 CCR5 NOTCH2 VEGFA | 7.89e-06 | 625 | 128 | 15 | GO:0051960 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 8.02e-06 | 7 | 128 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.96e-06 | 218 | 128 | 9 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | VEGFC COL3A1 PCSK5 SEMA4F LAMA1 LAMA3 GRN ITGA2B EZH2 FAS ADAM10 TGFBR2 FBLN1 FBN2 EFEMP1 CSF1 CCN1 LRP1 NGFR CCR5 MUC2 VEGFA | 1.22e-05 | 1280 | 128 | 22 | GO:2000145 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | VEGFC COL3A1 LAMA1 GRN ITGA2B ADAM12 LDLR TGFBR2 CCN1 BRPF1 LRP1 NGFR LRP2 MINAR1 NOTCH2 NOTCH3 VEGFA | 1.23e-05 | 817 | 128 | 17 | GO:0048514 |
| GeneOntologyBiologicalProcess | chordate embryonic development | COL3A1 PCSK5 SLC34A2 GRN ADAM10 LRP1B TGFBR2 KMT2D SEC24C CCN1 TRIM28 CCDC62 BRPF1 LRP2 PDS5A TCTN1 NOTCH2 VEGFA | 1.25e-05 | 906 | 128 | 18 | GO:0043009 |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 1.37e-05 | 24 | 128 | 4 | GO:1905146 | |
| GeneOntologyBiologicalProcess | tube development | VEGFC COL3A1 PCSK5 FAT4 ABCA12 LAMA1 GRN ITGA2B ADAM12 LDLR ITGB6 TGFBR2 CSF1 CCN1 BRPF1 LRP1 NGFR LRP2 MINAR1 TCTN1 NOTCH2 NOTCH3 VEGFA | 1.60e-05 | 1402 | 128 | 23 | GO:0035295 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | COL3A1 PCSK5 SLC34A2 GRN ADAM10 LRP1B TGFBR2 KMT2D SEC24C CCN1 TRIM28 CCDC62 BRPF1 LRP2 PDS5A TCTN1 NOTCH2 VEGFA | 1.75e-05 | 929 | 128 | 18 | GO:0009792 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | VEGFC SEMA4F COL5A2 CRIM1 TRIO CCND1 EZH2 FAS LDLR TGFBR2 EFEMP1 LMX1A SLIT1 NGFR CCR5 MINAR1 TWSG1 FST USH2A NOTCH3 VEGFA | 1.94e-05 | 1220 | 128 | 21 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | VEGFC SEMA4F EZH2 FAS LDLR LRP8 TENM4 SLIT1 LRP1 LRP2 CCR5 NOTCH2 VEGFA | 1.95e-05 | 515 | 128 | 13 | GO:0050767 |
| GeneOntologyBiologicalProcess | tube morphogenesis | VEGFC COL3A1 FAT4 LAMA1 GRN ITGA2B ADAM12 LDLR TGFBR2 CSF1 CCN1 BRPF1 LRP1 NGFR LRP2 MINAR1 TCTN1 NOTCH2 NOTCH3 VEGFA | 1.98e-05 | 1125 | 128 | 20 | GO:0035239 |
| GeneOntologyBiologicalProcess | in utero embryonic development | COL3A1 SLC34A2 GRN ADAM10 LRP1B TGFBR2 KMT2D SEC24C CCN1 TRIM28 CCDC62 TCTN1 NOTCH2 VEGFA | 2.05e-05 | 596 | 128 | 14 | GO:0001701 |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.05e-05 | 134 | 128 | 7 | GO:0003279 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | AKAP6 VEGFC VWC2 LAMA1 LAMC1 EZH2 LRP8 TGFBR2 FBN2 TENM4 CSF1 CCN1 DPF3 LRP1 NGFR LRP2 CCR5 BRD1 NOTCH2 VEGFA | 2.43e-05 | 1141 | 128 | 20 | GO:0045597 |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 2.58e-05 | 28 | 128 | 4 | GO:0007039 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | SEMA4F VLDLR SETX GRN EZH2 ADAM10 LRP8 EFEMP1 SLIT1 LRP1 NGFR CCR5 MINAR1 VEGFA | 2.74e-05 | 612 | 128 | 14 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of glial cell migration | 2.98e-05 | 29 | 128 | 4 | GO:1903975 | |
| GeneOntologyBiologicalProcess | embryo implantation | 3.16e-05 | 97 | 128 | 6 | GO:0007566 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 3.23e-05 | 197 | 128 | 8 | GO:0030509 | |
| GeneOntologyBiologicalProcess | epithelium development | VEGFC FAT4 ABCA12 LAMA1 LAMC1 CCND1 TECTA EZH2 FEM1B TGFBR2 CSF1 CCN1 TRIM28 BRPF1 NGFR LRP2 ROS1 FST MUC2 USH2A TCTN1 NOTCH2 VEGFA | 3.34e-05 | 1469 | 128 | 23 | GO:0060429 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | VEGFC VLDLR RANBP2 CCND1 EZH2 LRP8 TGFBR2 CSF1 CCN1 ROS1 NOTCH2 | 4.55e-05 | 405 | 128 | 11 | GO:0033674 |
| GeneOntologyBiologicalProcess | central nervous system development | COL3A1 ATRN VLDLR FAT4 GRN CD320 EZH2 LDLR LRP8 WDR47 TGFBR2 TENM4 LMX1A SLIT1 LRP1 NGFR LRP2 TWSG1 TCTN1 NOTCH3 | 4.77e-05 | 1197 | 128 | 20 | GO:0007417 |
| GeneOntologyBiologicalProcess | developmental growth | AKAP6 COL3A1 ATRN SEMA4F GRN EZH2 TGFBR2 EYS KMT2D TENM4 CSF1 TRIM28 SLIT1 LRP1 CCR5 NOTCH2 VEGFA | 4.89e-05 | 911 | 128 | 17 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 4.93e-05 | 12 | 128 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | response to BMP | 5.99e-05 | 215 | 128 | 8 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 5.99e-05 | 215 | 128 | 8 | GO:0071773 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 8.08e-05 | 14 | 128 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 8.08e-05 | 14 | 128 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 9.01e-05 | 169 | 128 | 7 | GO:0010977 | |
| GeneOntologyBiologicalProcess | regulation of growth | AKAP6 ATRN SEMA4F LRP12 GRN ADAM10 TGFBR2 CSF1 LMX1A SLIT1 LRP1 ROS1 CCR5 MINAR1 VEGFA | 9.66e-05 | 777 | 128 | 15 | GO:0040008 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 1.05e-04 | 233 | 128 | 8 | GO:0061351 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 COL5A2 COL19A1 LAMA1 LAMC1 ADAM10 MMP25 FBLN1 CCN1 LRP1 | 1.24e-04 | 377 | 128 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 COL5A2 COL19A1 LAMA1 LAMC1 ADAM10 MMP25 FBLN1 CCN1 LRP1 | 1.27e-04 | 378 | 128 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 COL5A2 COL19A1 LAMA1 LAMC1 ADAM10 MMP25 FBLN1 CCN1 LRP1 | 1.29e-04 | 379 | 128 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | VEGFC COL5A2 TECTA TGFBR2 FBN2 TENM4 CCN1 TRIM28 BRPF1 LRP2 PDS5A TWSG1 TCTN1 NOTCH2 | 1.40e-04 | 713 | 128 | 14 | GO:0048598 |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 1.41e-04 | 80 | 128 | 5 | GO:2000179 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 1.41e-04 | 80 | 128 | 5 | GO:0030514 | |
| GeneOntologyBiologicalProcess | regulation of cell development | VEGFC SEMA4F GRN EZH2 FAS LDLR LRP8 TGFBR2 TENM4 CSF1 BRPF1 SLIT1 LRP1 LRP2 CCR5 BRD1 NOTCH2 VEGFA | 1.45e-04 | 1095 | 128 | 18 | GO:0060284 |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.68e-04 | 83 | 128 | 5 | GO:0060976 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 1.76e-04 | 320 | 128 | 9 | GO:0002274 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.98e-04 | 135 | 128 | 6 | GO:2000177 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | PCSK5 VWC2 DEFB118 ABCA12 LAMA1 LAMA3 LAMC1 ADAM10 TGFBR2 FBLN1 CSF1 CCN1 LRP1 CCR5 TWSG1 VEGFA | 2.03e-04 | 927 | 128 | 16 | GO:0030155 |
| GeneOntologyBiologicalProcess | astrocyte activation involved in immune response | 2.27e-04 | 4 | 128 | 2 | GO:0002265 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 2.27e-04 | 4 | 128 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | Langerhans cell differentiation | 2.27e-04 | 4 | 128 | 2 | GO:0061520 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphangiogenesis | 2.27e-04 | 4 | 128 | 2 | GO:1901492 | |
| GeneOntologyBiologicalProcess | positive regulation of odontogenesis of dentin-containing tooth | 2.27e-04 | 4 | 128 | 2 | GO:0042488 | |
| GeneOntologyBiologicalProcess | forebrain development | COL3A1 FAT4 EZH2 LRP8 WDR47 LMX1A SLIT1 LRP2 TWSG1 TCTN1 NOTCH3 | 2.39e-04 | 489 | 128 | 11 | GO:0030900 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | VEGFC VLDLR RANBP2 CCND1 EZH2 LRP8 TGFBR2 CSF1 CCN1 ROS1 NOTCH2 | 2.43e-04 | 490 | 128 | 11 | GO:0051347 |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | AKAP6 VEGFC VLDLR FBXO11 GRN CCND1 EZH2 FAS LDLR LRP8 TGFBR2 CSF1 CCN1 RNFT2 SPON1 LRP1 NGFR LRP2 UHRF1 NOTCH2 VEGFA | 2.46e-04 | 1458 | 128 | 21 | GO:0051247 |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 3.01e-04 | 421 | 128 | 10 | GO:0048638 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | VEGFC COL3A1 COL5A2 GRN ITGA2B ADAM12 ITGB6 LRP8 TGFBR2 FBN2 TENM4 CCN1 BRPF1 NGFR LRP2 MINAR1 TWSG1 TCTN1 NOTCH2 NOTCH3 VEGFA | 3.09e-04 | 1483 | 128 | 21 | GO:0048646 |
| GeneOntologyBiologicalProcess | intracellular lipid transport | 3.27e-04 | 53 | 128 | 4 | GO:0032365 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite development | 3.30e-04 | 22 | 128 | 3 | GO:1900006 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 3.38e-04 | 149 | 128 | 6 | GO:0010811 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 3.42e-04 | 350 | 128 | 9 | GO:0045860 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 3.43e-04 | 210 | 128 | 7 | GO:0007219 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 3.50e-04 | 150 | 128 | 6 | GO:0090288 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | AKAP6 VEGFC VLDLR RANBP2 CCND1 EZH2 FAS LRP8 TGFBR2 CSF1 CCN1 ROS1 NOTCH2 VEGFA | 3.51e-04 | 780 | 128 | 14 | GO:0042327 |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 VWC2 COL5A2 VWF COL19A1 LRRN1 LAMA1 LAMA3 LAMC1 MUC5B TECTA ADAM10 MMP25 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 CCN1 OTOGL SPON1 LTBP1 ALB MUC2 USH2A VEGFA | 4.37e-15 | 656 | 130 | 27 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 VWC2 COL5A2 VWF COL19A1 LRRN1 LAMA1 LAMA3 LAMC1 MUC5B TECTA ADAM10 MMP25 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 CCN1 OTOGL SPON1 LTBP1 ALB MUC2 USH2A VEGFA | 4.71e-15 | 658 | 130 | 27 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 VWC2 COL5A2 VWF COL19A1 LAMA1 LAMA3 LAMC1 ADAM10 FBLN1 EYS FBN2 EFEMP1 MEGF6 CCN1 SPON1 LTBP1 ALB MUC2 USH2A VEGFA | 1.39e-11 | 530 | 130 | 21 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 7.10e-08 | 122 | 130 | 9 | GO:0005604 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL3A1 PCSK5 COL5A2 COL19A1 LAMC1 ADAM10 TSPAN5 CSF1 CCN1 AFP SPON1 LTBP1 ALB | 1.60e-07 | 332 | 130 | 13 | GO:0005788 |
| GeneOntologyCellularComponent | cell surface | VLDLR VWF ITGA2B FAS ADAM10 LDLR ITGB6 ADAM28 LRP8 MMP25 LY6D CD93 TGFBR2 LRP1 NGFR LRP2 ROS1 CCR5 ADGRE1 NOTCH2 NOTCH3 VEGFA | 1.32e-06 | 1111 | 130 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | laminin complex | 2.73e-05 | 10 | 130 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | receptor complex | VWC2 VLDLR ITGA2B LRP1B LDLR ITGB6 LRP8 TGFBR2 LRP1 LRP2 ROS1 NOTCH2 NOTCH3 | 6.93e-05 | 581 | 130 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | laminin-1 complex | 1.15e-04 | 3 | 130 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | laminin-3 complex | 1.15e-04 | 3 | 130 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.42e-04 | 80 | 130 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | platelet alpha granule | 2.89e-04 | 93 | 130 | 5 | GO:0031091 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.05e-04 | 519 | 130 | 11 | GO:0009897 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 4.99e-04 | 59 | 130 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | caveola | 6.52e-04 | 111 | 130 | 5 | GO:0005901 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 7.90e-04 | 7 | 130 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 8.08e-04 | 67 | 130 | 4 | GO:0031093 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 1.05e-03 | 8 | 130 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | side of membrane | VWF ITGA2B TECTA FAS LDLR ITGB6 MMP25 LY6D TGFBR2 LRP1 NGFR LRP2 CCR5 ADGRE1 | 1.11e-03 | 875 | 130 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | neuronal cell body | PCSK5 SEMA4F DNER LMTK2 FAS ADAM10 LRP8 WDR47 LRP1 NGFR LTBP1 BRD1 USH2A | 2.13e-03 | 835 | 130 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | plasma membrane raft | 2.27e-03 | 147 | 130 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.43e-03 | 12 | 130 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.43e-03 | 12 | 130 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | microfibril | 2.86e-03 | 13 | 130 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.33e-03 | 14 | 130 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 3.70e-03 | 237 | 130 | 6 | GO:0030136 | |
| HumanPheno | Abnormal atrioventricular valve morphology | COL3A1 COL5A2 VWF TRIO SLC34A2 FAS LDLR TGFBR2 FANCB KMT2D FBN2 GLA SEC24C NOTCH2 | 2.05e-05 | 350 | 57 | 14 | HP:0006705 |
| HumanPheno | Abnormal heart valve morphology | COL3A1 COL5A2 FAT4 VWF TRIO SLC34A2 MUC5B FAS LDLR TGFBR2 FANCB KMT2D FBN2 GLA SEC24C LTBP1 NOTCH2 NOTCH3 | 4.12e-05 | 588 | 57 | 18 | HP:0001654 |
| HumanPheno | Abnormal aortic valve morphology | VWF FAS LDLR TGFBR2 FANCB KMT2D FBN2 GLA SEC24C LTBP1 NOTCH2 NOTCH3 | 6.25e-05 | 289 | 57 | 12 | HP:0001646 |
| HumanPheno | Genital hernia | 7.15e-05 | 8 | 57 | 3 | HP:0100823 | |
| HumanPheno | Blepharochalasis | 7.15e-05 | 8 | 57 | 3 | HP:0010749 | |
| MousePheno | abnormal glomerular capillary endothelium morphology | 5.80e-07 | 21 | 113 | 5 | MP:0011453 | |
| MousePheno | abnormal artery morphology | COL3A1 PCSK5 CRIM1 FAS LDLR TGFBR2 FBLN1 CSF1 GLA CCN1 NGFR LRP2 LTBP1 NOTCH3 VEGFA | 2.50e-06 | 440 | 113 | 15 | MP:0002191 |
| MousePheno | abnormal blood vessel morphology | NPC1 COL3A1 PCSK5 COL5A2 VLDLR CRIM1 ABCA12 LAMA1 LAMC1 CD320 FAS ADAM10 LDLR BRAP MMP25 TGFBR2 FBLN1 EFEMP1 CSF1 GLA CCN1 PRICKLE3 NGFR LRP2 CCR5 LTBP1 NOTCH2 NOTCH3 VEGFA | 3.94e-06 | 1472 | 113 | 29 | MP:0001614 |
| MousePheno | abnormal ear morphology | FAT4 LRRN1 ABCA12 FBXO11 MUC5B TECTA FAS FBLN1 KMT2D FBN2 LMX1A NGFR LRP2 TWSG1 USH2A | 5.58e-06 | 470 | 113 | 15 | MP:0002102 |
| MousePheno | abnormal capillary morphology | 1.00e-05 | 93 | 113 | 7 | MP:0003658 | |
| MousePheno | abnormal glial cell morphology | NPC1 ATRN LAMA1 DNER LAMC1 GRN LDLR TENM4 CSF1 NGFR NOTCH3 VEGFA | 2.23e-05 | 345 | 113 | 12 | MP:0003634 |
| MousePheno | abnormal kidney vasculature morphology | 2.68e-05 | 73 | 113 | 6 | MP:0000530 | |
| MousePheno | abnormal glomerular capillary morphology | 3.70e-05 | 47 | 113 | 5 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 4.10e-05 | 48 | 113 | 5 | MP:0011310 | |
| MousePheno | abnormal aortic arch morphology | 4.97e-05 | 119 | 113 | 7 | MP:0004113 | |
| MousePheno | abnormal CNS glial cell morphology | 7.03e-05 | 272 | 113 | 10 | MP:0000952 | |
| MousePheno | abnormal axial skeleton morphology | PCSK5 COL5A2 FAT4 CRIM1 LAMA3 FBXO11 CCND1 EZH2 ITGB6 TGFBR2 FBLN1 KMT2D FBN2 EFEMP1 TENM4 CSF1 LMX1A NGFR LRP2 PDS5A LTBP1 TWSG1 FST NOTCH2 NOTCH3 VEGFA | 7.89e-05 | 1458 | 113 | 26 | MP:0002114 |
| MousePheno | abnormal craniofacial morphology | AKAP6 NPC1 PCSK5 CRIM1 ABCA12 LAMA3 FBXO11 CCND1 ADAM10 ITGB6 FBLN1 KMT2D FBN2 CSF1 LMX1A LRP1 NGFR LRP2 UHRF1 PDS5A LTBP1 TWSG1 FST CRAMP1 VEGFA | 7.91e-05 | 1372 | 113 | 25 | MP:0000428 |
| MousePheno | craniofacial phenotype | AKAP6 NPC1 PCSK5 CRIM1 ABCA12 LAMA3 FBXO11 CCND1 ADAM10 ITGB6 FBLN1 KMT2D FBN2 CSF1 LMX1A LRP1 NGFR LRP2 UHRF1 PDS5A LTBP1 TWSG1 FST CRAMP1 VEGFA | 7.91e-05 | 1372 | 113 | 25 | MP:0005382 |
| MousePheno | abnormal coronary artery morphology | 8.23e-05 | 29 | 113 | 4 | MP:0004111 | |
| MousePheno | hemorrhage | PCSK5 VWF CRIM1 LAMC1 ITGA2B FAS BRAP TGFBR2 FBLN1 CCN1 LRP1 NGFR TWSG1 TCTN1 NOTCH2 VEGFA | 8.43e-05 | 664 | 113 | 16 | MP:0001914 |
| MousePheno | abnormal aorta morphology | 8.65e-05 | 225 | 113 | 9 | MP:0000272 | |
| MousePheno | abnormal thoracic aorta morphology | 1.06e-04 | 134 | 113 | 7 | MP:0010468 | |
| MousePheno | hearing/vestibular/ear phenotype | FAT4 LRRN1 ABCA12 FBXO11 MUC5B TECTA FAS LDLR FBLN1 KMT2D FBN2 CSF1 LMX1A OTOGL NGFR LRP2 TWSG1 USH2A NOTCH3 | 1.09e-04 | 905 | 113 | 19 | MP:0005377 |
| MousePheno | abnormal skin appearance | COL3A1 COL5A2 CRIM1 ABCA12 LAMA3 GRN FAS LDLR FBLN1 EFEMP1 LMX1A BRD1 FST | 1.14e-04 | 473 | 113 | 13 | MP:0009931 |
| MousePheno | abnormal retina ganglion layer morphology | 1.18e-04 | 95 | 113 | 6 | MP:0005241 | |
| MousePheno | dilated capillary | 1.39e-04 | 13 | 113 | 3 | MP:0020326 | |
| MousePheno | abnormal blood circulation | VEGFC PCSK5 VWF CRIM1 LAMC1 ITGA2B FAS BRAP TGFBR2 FBLN1 CCN1 LRP1 NGFR TWSG1 TCTN1 NOTCH2 NOTCH3 VEGFA | 1.42e-04 | 845 | 113 | 18 | MP:0002128 |
| MousePheno | vascular ring | 1.75e-04 | 35 | 113 | 4 | MP:0010466 | |
| MousePheno | tight skin | 1.75e-04 | 14 | 113 | 3 | MP:0001198 | |
| MousePheno | abnormal systemic artery morphology | 1.76e-04 | 304 | 113 | 10 | MP:0011655 | |
| MousePheno | abnormal muscle morphology | COL3A1 COL19A1 TRIO LAMC1 EZH2 FAS ADAM12 FBLN1 FBN2 EFEMP1 CSF1 GLA LRP1 NGFR LRP2 CCR5 LTBP1 FST NOTCH2 NOTCH3 VEGFA | 1.87e-04 | 1106 | 113 | 21 | MP:0002108 |
| MousePheno | abnormal vertebral column morphology | PCSK5 COL5A2 FAT4 CRIM1 EZH2 TGFBR2 FBLN1 FBN2 EFEMP1 TENM4 LMX1A PDS5A TWSG1 FST NOTCH2 NOTCH3 VEGFA | 1.88e-04 | 787 | 113 | 17 | MP:0004703 |
| MousePheno | perinatal lethality, complete penetrance | FAT4 CRIM1 TRIO ABCA12 LAMC1 FBXO11 EZH2 FBLN1 CCN1 LRP1 LRP2 PDS5A LTBP1 FST NOTCH2 VEGFA | 1.89e-04 | 712 | 113 | 16 | MP:0011089 |
| MousePheno | thin retina ganglion layer | 2.18e-04 | 15 | 113 | 3 | MP:0008507 | |
| MousePheno | abnormal interatrial septum morphology | 2.27e-04 | 107 | 113 | 6 | MP:0000282 | |
| MousePheno | dilated vasculature | 2.52e-04 | 70 | 113 | 5 | MP:0004938 | |
| MousePheno | abnormal neural tube morphology | PCSK5 FAT4 LAMC1 ADAM10 BRAP FBLN1 TENM4 LMX1A TRIM28 LRP2 UHRF1 LTBP1 BRD1 TCTN1 | 2.89e-04 | 591 | 113 | 14 | MP:0002151 |
| MousePheno | abnormal mouth morphology | PCSK5 ABCA12 LAMA3 FBXO11 CCND1 ITGB6 CSF1 NGFR LRP2 PDS5A LTBP1 TWSG1 FST CRAMP1 VEGFA | 3.17e-04 | 670 | 113 | 15 | MP:0000452 |
| MousePheno | abnormal jaw morphology | LAMA3 CCND1 ITGB6 FBLN1 KMT2D FBN2 CSF1 NGFR LRP2 LTBP1 TWSG1 FST VEGFA | 3.46e-04 | 530 | 113 | 13 | MP:0000454 |
| MousePheno | abnormal facial morphology | NPC1 PCSK5 ABCA12 LAMA3 FBXO11 CCND1 ITGB6 FBLN1 KMT2D CSF1 NGFR LRP2 PDS5A LTBP1 TWSG1 FST CRAMP1 VEGFA | 3.52e-04 | 910 | 113 | 18 | MP:0003743 |
| MousePheno | abnormal hepatocyte physiology | 3.52e-04 | 116 | 113 | 6 | MP:0010080 | |
| MousePheno | increased kidney apoptosis | 3.92e-04 | 43 | 113 | 4 | MP:0011368 | |
| MousePheno | abnormal nervous system development | PCSK5 VLDLR FAT4 DNER LAMC1 ADAM10 BRAP LRP8 FBLN1 TENM4 LMX1A TRIM28 NGFR LRP2 UHRF1 LTBP1 TWSG1 BRD1 FST TCTN1 NOTCH3 VEGFA | 4.07e-04 | 1257 | 113 | 22 | MP:0003861 |
| MousePheno | decreased skeletal muscle size | 4.96e-04 | 81 | 113 | 5 | MP:0010240 | |
| MousePheno | small thymus | 5.16e-04 | 286 | 113 | 9 | MP:0000706 | |
| MousePheno | abnormal eye electrophysiology | 5.21e-04 | 228 | 113 | 8 | MP:0005551 | |
| MousePheno | reduced cerebellar foliation | 5.30e-04 | 20 | 113 | 3 | MP:0009719 | |
| MousePheno | abnormal blood vessel endothelium morphology | 5.55e-04 | 83 | 113 | 5 | MP:0009489 | |
| MousePheno | abnormal embryonic tissue morphology | PCSK5 FAT4 CRIM1 SLC34A2 LAMC1 EZH2 ADAM10 BRAP FBLN1 TENM4 LMX1A TRIM28 LRP1 LRP2 UHRF1 LTBP1 TWSG1 BRD1 TCTN1 VEGFA | 5.76e-04 | 1116 | 113 | 20 | MP:0002085 |
| MousePheno | abnormal truncus arteriosus septation | 5.87e-04 | 84 | 113 | 5 | MP:0010454 | |
| MousePheno | renal glomerulus hypertrophy | 6.15e-04 | 21 | 113 | 3 | MP:0011294 | |
| MousePheno | abnormal Kupffer cell morphology | 6.15e-04 | 21 | 113 | 3 | MP:0008114 | |
| MousePheno | abnormal cochlear labyrinth morphology | 6.36e-04 | 235 | 113 | 8 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 6.36e-04 | 235 | 113 | 8 | MP:0003169 | |
| MousePheno | abnormal liver perisinusoidal space morphology | 6.37e-04 | 5 | 113 | 2 | MP:0008988 | |
| MousePheno | kidney microaneurysm | 6.37e-04 | 5 | 113 | 2 | MP:0010451 | |
| MousePheno | abnormal peritubular capillary morphology | 6.37e-04 | 5 | 113 | 2 | MP:0011321 | |
| MousePheno | abnormal nephron morphology | FAT4 CRIM1 LAMC1 GRN FAS FBLN1 LRP2 PDS5A LTBP1 NOTCH2 VEGFA | 6.60e-04 | 426 | 113 | 11 | MP:0003881 |
| MousePheno | perinatal lethality | AKAP6 COL5A2 FAT4 CRIM1 TRIO ABCA12 LAMC1 FBXO11 EZH2 FBLN1 CCN1 LRP1 NGFR LRP2 PDS5A LTBP1 TWSG1 FST NOTCH2 VEGFA | 6.74e-04 | 1130 | 113 | 20 | MP:0002081 |
| MousePheno | atrial septal defect | 7.26e-04 | 88 | 113 | 5 | MP:0010403 | |
| MousePheno | abnormal inner ear morphology | 7.80e-04 | 303 | 113 | 9 | MP:0000026 | |
| MousePheno | abnormal femur compact bone thickness | 8.10e-04 | 23 | 113 | 3 | MP:0013622 | |
| MousePheno | abnormal skeletal muscle morphology | TRIO LAMC1 ADAM12 FBN2 EFEMP1 CSF1 LRP1 NGFR CCR5 FST NOTCH3 VEGFA | 8.21e-04 | 508 | 113 | 12 | MP:0000759 |
| MousePheno | skin lesions | 8.45e-04 | 91 | 113 | 5 | MP:0001212 | |
| MousePheno | abnormal kidney apoptosis | 8.74e-04 | 53 | 113 | 4 | MP:0011367 | |
| MousePheno | perimembraneous ventricular septal defect | 8.88e-04 | 92 | 113 | 5 | MP:0010418 | |
| MousePheno | abnormal cochlea morphology | 9.04e-04 | 248 | 113 | 8 | MP:0000031 | |
| MousePheno | decreased incisor number | 9.20e-04 | 24 | 113 | 3 | MP:0030609 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 9.32e-04 | 93 | 113 | 5 | MP:0008823 | |
| MousePheno | abnormal skeletal muscle size | 9.32e-04 | 93 | 113 | 5 | MP:0009458 | |
| MousePheno | abnormal arteriole morphology | 9.51e-04 | 6 | 113 | 2 | MP:0004112 | |
| MousePheno | abnormal neural tube closure | 9.72e-04 | 378 | 113 | 10 | MP:0003720 | |
| MousePheno | abnormal craniofacial bone morphology | CRIM1 LAMA3 FBXO11 CCND1 ITGB6 FBLN1 KMT2D FBN2 CSF1 LMX1A NGFR LRP2 LTBP1 TWSG1 FST VEGFA | 9.78e-04 | 827 | 113 | 16 | MP:0002116 |
| MousePheno | abnormal viscerocranium morphology | LAMA3 CCND1 ITGB6 FBLN1 KMT2D FBN2 CSF1 NGFR LRP2 LTBP1 TWSG1 FST VEGFA | 9.89e-04 | 593 | 113 | 13 | MP:0005274 |
| MousePheno | limbs/digits/tail phenotype | PCSK5 FAT4 CRIM1 LAMC1 FBXO11 EZH2 ITGB6 FBN2 CSF1 LMX1A SPON1 LRP1 NGFR LRP2 PAPPA LTBP1 TWSG1 FST TCTN1 NOTCH2 VEGFA | 1.04e-03 | 1258 | 113 | 21 | MP:0005371 |
| MousePheno | abnormal apoptosis | PCSK5 FAT4 SETX CRIM1 LAMA1 GRN MUC5B FAS TRIM27 LDLR FANCB FBLN1 FBN2 TENM4 CSF1 CCN1 NGFR LRP2 TWSG1 BRD1 NOTCH2 VEGFA | 1.10e-03 | 1353 | 113 | 22 | MP:0001648 |
| MousePheno | abnormal neuron number | 1.15e-03 | 456 | 113 | 11 | MP:0008946 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | VEGFC FAT4 CRIM1 TRIO ABCA12 LAMA3 LAMC1 FBXO11 EZH2 FBLN1 CCN1 LRP1 LRP2 PDS5A LTBP1 TWSG1 BRD1 FST TCTN1 NOTCH2 VEGFA | 1.16e-03 | 1269 | 113 | 21 | MP:0011111 |
| MousePheno | internal hemorrhage | 1.16e-03 | 387 | 113 | 10 | MP:0001634 | |
| MousePheno | abnormal kidney cell proliferation | 1.17e-03 | 26 | 113 | 3 | MP:0011439 | |
| MousePheno | abnormal programmed cell death | PCSK5 FAT4 SETX CRIM1 LAMA1 GRN MUC5B FAS TRIM27 LDLR FANCB FBLN1 FBN2 TENM4 CSF1 CCN1 NGFR LRP2 TWSG1 BRD1 NOTCH2 VEGFA | 1.17e-03 | 1360 | 113 | 22 | MP:0014355 |
| MousePheno | abnormal heart septum morphology | 1.18e-03 | 388 | 113 | 10 | MP:0006113 | |
| MousePheno | abnormal eye physiology | VLDLR RANBP2 LAMA1 GRN CCND1 ADAM32 FAS FBLN1 CSF1 PRICKLE3 NGFR USH2A VEGFA | 1.20e-03 | 606 | 113 | 13 | MP:0005253 |
| MousePheno | abnormal cerebellar foliation | 1.23e-03 | 58 | 113 | 4 | MP:0000857 | |
| MousePheno | ventricular septal defect | 1.25e-03 | 261 | 113 | 8 | MP:0010402 | |
| MousePheno | abnormal membranous labyrinth morphology | 1.29e-03 | 262 | 113 | 8 | MP:0000035 | |
| MousePheno | abnormal choroid vasculature morphology | 1.31e-03 | 27 | 113 | 3 | MP:0006237 | |
| MousePheno | abnormal coronary vessel morphology | 1.31e-03 | 59 | 113 | 4 | MP:0010551 | |
| MousePheno | abnormal skeletal muscle mass | 1.31e-03 | 149 | 113 | 6 | MP:0004817 | |
| MousePheno | increased femur compact bone thickness | 1.32e-03 | 7 | 113 | 2 | MP:0013623 | |
| MousePheno | increased macrophage derived foam cell number | 1.32e-03 | 7 | 113 | 2 | MP:0004778 | |
| MousePheno | foam cell reticulosis | 1.32e-03 | 7 | 113 | 2 | MP:0009841 | |
| MousePheno | absent Langerhans cell | 1.32e-03 | 7 | 113 | 2 | MP:0008118 | |
| MousePheno | right aortic arch | 1.39e-03 | 60 | 113 | 4 | MP:0004158 | |
| MousePheno | abnormal bone structure | PCSK5 ATRN SEMA4F ADAM32 EZH2 VWCE FBN2 EFEMP1 TENM4 CSF1 MEGF6 DPF3 SPON1 BRPF1 LRP2 PAPPA LTBP1 TWSG1 FST CRAMP1 NOTCH2 NOTCH3 | 1.40e-03 | 1379 | 113 | 22 | MP:0003795 |
| MousePheno | abnormal limb morphology | PCSK5 CRIM1 LAMC1 FBXO11 EZH2 ITGB6 FBN2 CSF1 SPON1 LRP1 NGFR PAPPA LTBP1 TWSG1 FST TCTN1 NOTCH2 VEGFA | 1.46e-03 | 1028 | 113 | 18 | MP:0002109 |
| Domain | Growth_fac_rcpt_ | PCSK5 ATRN VLDLR FAT4 CRIM1 LAMA1 DNER LAMA3 LAMC1 VWCE LRP1B LDLR LRP8 CD93 FBLN1 EYS FBN2 EFEMP1 MEGF6 CCN1 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 2.72e-30 | 156 | 131 | 27 | IPR009030 |
| Domain | EGF-like_dom | PCSK5 ATRN VLDLR FAT4 LAMA1 DNER LAMA3 LAMC1 ADAM32 TECTA VWCE ADAM12 LRP1B LDLR ADAM28 LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 TENM4 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 3.83e-30 | 249 | 131 | 31 | IPR000742 |
| Domain | EGF | PCSK5 ATRN VLDLR FAT4 LAMA1 DNER LAMA3 LAMC1 ADAM32 TECTA VWCE LRP1B LDLR ADAM28 LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 TENM4 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 1.67e-29 | 235 | 131 | 30 | SM00181 |
| Domain | EGF_1 | ATRN VLDLR FAT4 LAMA1 DNER LAMA3 LAMC1 ADAM32 VWCE ADAM12 LRP1B LDLR ITGB6 ADAM28 LRP8 SNED1 FBLN1 EYS FBN2 EFEMP1 TENM4 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 USH2A NOTCH2 NOTCH3 | 2.04e-28 | 255 | 131 | 30 | PS00022 |
| Domain | EGF-like_CS | ATRN VLDLR FAT4 LAMA1 DNER LAMA3 LAMC1 ADAM32 VWCE ADAM12 LRP1B LDLR ITGB6 ADAM28 LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 TENM4 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 4.14e-28 | 261 | 131 | 30 | IPR013032 |
| Domain | EGF_2 | ATRN VLDLR FAT4 LAMA1 DNER LAMA3 LAMC1 ADAM32 VWCE ADAM12 LRP1B LDLR ITGB6 ADAM28 LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 TENM4 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 6.58e-28 | 265 | 131 | 30 | PS01186 |
| Domain | EGF_Ca-bd_CS | VLDLR FAT4 DNER VWCE LRP1B LDLR LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 7.04e-26 | 97 | 131 | 21 | IPR018097 |
| Domain | EGF_CA | VLDLR FAT4 DNER VWCE LRP1B LDLR LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 1.12e-25 | 99 | 131 | 21 | PS01187 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | VLDLR FAT4 DNER VWCE LRP1B LDLR LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 5.33e-25 | 106 | 131 | 21 | IPR000152 |
| Domain | EGF_3 | ATRN VLDLR FAT4 DNER ADAM32 VWCE ADAM12 LRP1B LDLR ADAM28 LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 TENM4 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 5.89e-24 | 235 | 131 | 26 | PS50026 |
| Domain | ASX_HYDROXYL | VLDLR FAT4 DNER VWCE LRP1B LDLR LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 6.19e-24 | 100 | 131 | 20 | PS00010 |
| Domain | EGF_CA | VLDLR FAT4 DNER VWCE LRP1B LDLR LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 1.25e-23 | 122 | 131 | 21 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | VLDLR FAT4 DNER VWCE LRP1B LDLR LRP8 CD93 SNED1 FBLN1 EYS FBN2 EFEMP1 MEGF6 SLIT1 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 1.80e-23 | 124 | 131 | 21 | IPR001881 |
| Domain | EGF_CA | VLDLR FAT4 VWCE LRP1B LDLR LRP8 CD93 FBLN1 FBN2 EFEMP1 MEGF6 LRP1 LRP2 LTBP1 ADGRE1 NOTCH2 NOTCH3 | 2.19e-20 | 86 | 131 | 17 | PF07645 |
| Domain | EGF | ATRN VLDLR DNER TECTA LRP1B LRP8 CD93 SNED1 EYS MEGF6 SLIT1 LRP1 LRP2 LTBP1 NOTCH2 NOTCH3 | 5.00e-16 | 126 | 131 | 16 | PF00008 |
| Domain | VWFC_2 | COL3A1 VWC2 COL5A2 VWF CHRDL2 CRIM1 MUC5B TECTA VWCE CCN1 MUC2 | 1.35e-15 | 38 | 131 | 11 | PS50184 |
| Domain | VWC | COL3A1 VWC2 COL5A2 VWF CHRDL2 CRIM1 MUC5B TECTA VWCE CCN1 MUC2 | 1.35e-15 | 38 | 131 | 11 | SM00214 |
| Domain | VWF_dom | COL3A1 VWC2 COL5A2 VWF CHRDL2 CRIM1 MUC5B TECTA VWCE CCN1 MUC2 | 4.69e-15 | 42 | 131 | 11 | IPR001007 |
| Domain | VWFC_1 | 4.43e-14 | 36 | 131 | 10 | PS01208 | |
| Domain | cEGF | 8.78e-14 | 26 | 131 | 9 | PF12662 | |
| Domain | cEGF | 8.78e-14 | 26 | 131 | 9 | IPR026823 | |
| Domain | hEGF | 1.92e-13 | 28 | 131 | 9 | PF12661 | |
| Domain | VWC | 1.92e-13 | 28 | 131 | 9 | PF00093 | |
| Domain | LY | 4.36e-12 | 15 | 131 | 7 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.36e-12 | 15 | 131 | 7 | IPR000033 | |
| Domain | EGF_extracell | 1.14e-11 | 60 | 131 | 10 | IPR013111 | |
| Domain | EGF_2 | 1.14e-11 | 60 | 131 | 10 | PF07974 | |
| Domain | Ldl_recept_a | 2.23e-11 | 45 | 131 | 9 | PF00057 | |
| Domain | - | 2.75e-11 | 46 | 131 | 9 | 4.10.400.10 | |
| Domain | LDLRA_1 | 4.14e-11 | 48 | 131 | 9 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 5.04e-11 | 49 | 131 | 9 | IPR002172 | |
| Domain | LDLa | 5.04e-11 | 49 | 131 | 9 | SM00192 | |
| Domain | LDLRA_2 | 5.04e-11 | 49 | 131 | 9 | PS50068 | |
| Domain | - | 2.42e-10 | 39 | 131 | 8 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 3.01e-10 | 40 | 131 | 8 | IPR023415 | |
| Domain | Ldl_recept_b | 3.04e-10 | 14 | 131 | 6 | PF00058 | |
| Domain | LDLRB | 3.04e-10 | 14 | 131 | 6 | PS51120 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.85e-10 | 46 | 131 | 8 | IPR011042 | |
| Domain | VWC_out | 2.67e-09 | 19 | 131 | 6 | SM00215 | |
| Domain | TIL_dom | 2.99e-08 | 14 | 131 | 5 | IPR002919 | |
| Domain | CTCK_1 | 1.25e-07 | 18 | 131 | 5 | PS01185 | |
| Domain | EGF_Lam | 1.46e-07 | 35 | 131 | 6 | SM00180 | |
| Domain | Laminin_EGF | 1.46e-07 | 35 | 131 | 6 | PF00053 | |
| Domain | Laminin_G | 1.59e-07 | 58 | 131 | 7 | IPR001791 | |
| Domain | PHD | 2.07e-07 | 89 | 131 | 8 | SM00249 | |
| Domain | LAM_G_DOMAIN | 2.44e-07 | 38 | 131 | 6 | PS50025 | |
| Domain | Laminin_EGF | 2.44e-07 | 38 | 131 | 6 | IPR002049 | |
| Domain | Znf_PHD | 2.46e-07 | 91 | 131 | 8 | IPR001965 | |
| Domain | Laminin_G_2 | 3.35e-07 | 40 | 131 | 6 | PF02210 | |
| Domain | - | 3.44e-07 | 95 | 131 | 8 | 2.60.120.200 | |
| Domain | ZF_PHD_2 | 3.44e-07 | 95 | 131 | 8 | PS50016 | |
| Domain | ZF_PHD_1 | 3.73e-07 | 96 | 131 | 8 | PS01359 | |
| Domain | CT | 3.76e-07 | 22 | 131 | 5 | SM00041 | |
| Domain | LamG | 6.02e-07 | 44 | 131 | 6 | SM00282 | |
| Domain | Fol_N | 7.34e-07 | 11 | 131 | 4 | IPR003645 | |
| Domain | FOLN | 7.34e-07 | 11 | 131 | 4 | SM00274 | |
| Domain | Cys_knot_C | 7.46e-07 | 25 | 131 | 5 | IPR006207 | |
| Domain | CTCK_2 | 7.46e-07 | 25 | 131 | 5 | PS01225 | |
| Domain | C8 | 1.10e-06 | 12 | 131 | 4 | PF08742 | |
| Domain | TIL | 1.10e-06 | 12 | 131 | 4 | PF01826 | |
| Domain | Znf_PHD-finger | 1.35e-06 | 79 | 131 | 7 | IPR019787 | |
| Domain | Unchr_dom_Cys-rich | 1.57e-06 | 13 | 131 | 4 | IPR014853 | |
| Domain | C8 | 1.57e-06 | 13 | 131 | 4 | SM00832 | |
| Domain | EGF_LAM_2 | 1.95e-06 | 30 | 131 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 1.95e-06 | 30 | 131 | 5 | PS01248 | |
| Domain | VWF_type-D | 3.94e-06 | 16 | 131 | 4 | IPR001846 | |
| Domain | Laminin_N | 3.94e-06 | 16 | 131 | 4 | IPR008211 | |
| Domain | VWFD | 3.94e-06 | 16 | 131 | 4 | PS51233 | |
| Domain | LamNT | 3.94e-06 | 16 | 131 | 4 | SM00136 | |
| Domain | VWD | 3.94e-06 | 16 | 131 | 4 | SM00216 | |
| Domain | LAMININ_NTER | 3.94e-06 | 16 | 131 | 4 | PS51117 | |
| Domain | Laminin_N | 3.94e-06 | 16 | 131 | 4 | PF00055 | |
| Domain | VWD | 3.94e-06 | 16 | 131 | 4 | PF00094 | |
| Domain | Znf_FYVE_PHD | 9.30e-06 | 147 | 131 | 8 | IPR011011 | |
| Domain | - | 1.03e-05 | 20 | 131 | 4 | 4.10.70.10 | |
| Domain | Notch_dom | 1.16e-05 | 7 | 131 | 3 | IPR000800 | |
| Domain | Notch | 1.16e-05 | 7 | 131 | 3 | PF00066 | |
| Domain | NL | 1.16e-05 | 7 | 131 | 3 | SM00004 | |
| Domain | Disintegrin | 1.26e-05 | 21 | 131 | 4 | PF00200 | |
| Domain | DISIN | 1.26e-05 | 21 | 131 | 4 | SM00050 | |
| Domain | PHD | 1.44e-05 | 75 | 131 | 6 | PF00628 | |
| Domain | EPHD | 1.53e-05 | 22 | 131 | 4 | PS51805 | |
| Domain | - | USP49 PHF7 TRIM27 BRAP KMT2D RNF125 RNFT2 TRIM28 DPF3 BRPF1 UHRF1 BRD1 SP140 | 1.67e-05 | 449 | 131 | 13 | 3.30.40.10 |
| Domain | LAMININ_IVA | 1.84e-05 | 8 | 131 | 3 | PS51115 | |
| Domain | Laminin_B | 1.84e-05 | 8 | 131 | 3 | PF00052 | |
| Domain | LamB | 1.84e-05 | 8 | 131 | 3 | SM00281 | |
| Domain | Laminin_IV | 1.84e-05 | 8 | 131 | 3 | IPR000034 | |
| Domain | Znf_RING/FYVE/PHD | USP49 PHF7 TRIM27 BRAP KMT2D RNF125 RNFT2 TRIM28 DPF3 BRPF1 UHRF1 BRD1 SP140 | 2.10e-05 | 459 | 131 | 13 | IPR013083 |
| Domain | - | 2.24e-05 | 81 | 131 | 6 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 2.24e-05 | 81 | 131 | 6 | IPR024079 | |
| Domain | ConA-like_dom | 2.44e-05 | 219 | 131 | 9 | IPR013320 | |
| Domain | TB_dom | 2.75e-05 | 9 | 131 | 3 | IPR017878 | |
| Domain | TB | 2.75e-05 | 9 | 131 | 3 | PS51364 | |
| Domain | DUF5050 | 4.88e-05 | 2 | 131 | 2 | IPR032485 | |
| Domain | AKAP6/CEP68 | 4.88e-05 | 2 | 131 | 2 | IPR026696 | |
| Domain | DUF5050 | 4.88e-05 | 2 | 131 | 2 | PF16472 | |
| Domain | BROMODOMAIN_1 | 1.28e-04 | 37 | 131 | 4 | PS00633 | |
| Domain | DUF3454 | 1.46e-04 | 3 | 131 | 2 | PF11936 | |
| Domain | Serum_albumin/AFP/Afamin | 1.46e-04 | 3 | 131 | 2 | IPR021177 | |
| Domain | DUF3454_notch | 1.46e-04 | 3 | 131 | 2 | IPR024600 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL5A2 VWF COL19A1 LAMA1 LAMA3 LAMC1 ITGA2B ADAM12 ADAM10 ITGB6 MMP25 FBLN1 FBN2 EFEMP1 LTBP1 | 2.00e-10 | 300 | 97 | 16 | M610 |
| Pathway | WP_FOCAL_ADHESION | VEGFC COL3A1 COL5A2 VWF LAMA1 LAMA3 LAMC1 CCND1 ITGA2B ITGB6 VEGFA | 6.15e-08 | 187 | 97 | 11 | MM15913 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.06e-07 | 84 | 97 | 8 | M7098 | |
| Pathway | KEGG_FOCAL_ADHESION | VEGFC COL3A1 COL5A2 VWF LAMA1 LAMA3 LAMC1 CCND1 ITGA2B ITGB6 VEGFA | 1.16e-07 | 199 | 97 | 11 | M7253 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL5A2 VWF COL19A1 ITGA2B ADAM12 ADAM10 ITGB6 MMP25 FBN2 MEGF6 LTBP1 | 1.96e-07 | 258 | 97 | 12 | MM14572 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.71e-07 | 76 | 97 | 7 | M27219 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | VEGFC COL3A1 COL5A2 VWF LAMA1 LAMA3 LAMC1 ITGA2B ITGB6 CSF1 NGFR VEGFA | 1.05e-06 | 302 | 97 | 12 | M39719 |
| Pathway | WP_FOCAL_ADHESION | 1.09e-06 | 199 | 97 | 10 | M39402 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.67e-06 | 120 | 97 | 8 | MM14982 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.73e-06 | 30 | 97 | 5 | M27772 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.15e-06 | 124 | 97 | 8 | M27285 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | VEGFC COL3A1 COL5A2 VWF LAMA1 LAMA3 LAMC1 ITGA2B ITGB6 CSF1 NGFR VEGFA | 2.34e-06 | 326 | 97 | 12 | MM15917 |
| Pathway | PID_NOTCH_PATHWAY | 3.05e-06 | 59 | 97 | 6 | M17 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.09e-06 | 37 | 97 | 5 | M27134 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.32e-06 | 140 | 97 | 8 | M587 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.91e-06 | 66 | 97 | 6 | M18 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 8.56e-06 | 41 | 97 | 5 | M27778 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.09e-05 | 43 | 97 | 5 | M53 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.22e-05 | 44 | 97 | 5 | M26969 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.88e-05 | 48 | 97 | 5 | M27642 | |
| Pathway | WP_PI3KAKT_SIGNALING | VEGFC VWF LAMA1 LAMA3 LAMC1 CCND1 ITGA2B ITGB6 CSF1 NGFR VEGFA | 2.08e-05 | 339 | 97 | 11 | M39736 |
| Pathway | WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT | 2.80e-05 | 26 | 97 | 4 | M46461 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.27e-05 | 27 | 97 | 4 | M39545 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 5.01e-05 | 11 | 97 | 3 | M158 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.19e-05 | 59 | 97 | 5 | M27218 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 6.60e-05 | 62 | 97 | 5 | MM14686 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 8.59e-05 | 13 | 97 | 3 | M42551 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.33e-04 | 114 | 97 | 6 | MM14571 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.54e-04 | 74 | 97 | 5 | M160 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 1.64e-04 | 75 | 97 | 5 | M27032 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.75e-04 | 76 | 97 | 5 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.10e-04 | 79 | 97 | 5 | M27643 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.12e-04 | 43 | 97 | 4 | M39565 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.53e-04 | 45 | 97 | 4 | MM15344 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.79e-04 | 84 | 97 | 5 | M3228 | |
| Pathway | WP_HYPERTROPHY_MODEL | 2.83e-04 | 19 | 97 | 3 | MM15938 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.83e-04 | 19 | 97 | 3 | MM15512 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 2.87e-04 | 381 | 97 | 10 | M48063 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.95e-04 | 85 | 97 | 5 | M16441 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.99e-04 | 47 | 97 | 4 | MM14925 | |
| Pathway | WP_HYPERTROPHY_MODEL | 3.31e-04 | 20 | 97 | 3 | M39674 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.97e-04 | 325 | 97 | 9 | M12868 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 4.29e-04 | 198 | 97 | 7 | M18311 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4 | 4.42e-04 | 22 | 97 | 3 | M42574 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 4.62e-04 | 5 | 97 | 2 | M27411 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 4.76e-04 | 53 | 97 | 4 | MM15880 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 5.18e-04 | 96 | 97 | 5 | M39581 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.18e-04 | 96 | 97 | 5 | M39834 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 5.49e-04 | 55 | 97 | 4 | M39351 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 6.25e-04 | 100 | 97 | 5 | M27158 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 6.51e-04 | 25 | 97 | 3 | M39713 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 6.51e-04 | 25 | 97 | 3 | M118 | |
| Pathway | BIOCARTA_LDL_PATHWAY | 6.90e-04 | 6 | 97 | 2 | M22051 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 6.90e-04 | 6 | 97 | 2 | M27068 | |
| Pathway | WP_CANCER_PATHWAYS | VEGFC LAMA1 LAMA3 LAMC1 CCND1 ITGA2B FAS TGFBR2 NOTCH2 NOTCH3 VEGFA | 7.11e-04 | 507 | 97 | 11 | M48302 |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 7.18e-04 | 59 | 97 | 4 | M39886 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 7.65e-04 | 60 | 97 | 4 | M40048 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 8.19e-04 | 27 | 97 | 3 | M33 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 8.67e-04 | 439 | 97 | 10 | M42563 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 9.62e-04 | 7 | 97 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 9.62e-04 | 7 | 97 | 2 | M22049 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 9.62e-04 | 7 | 97 | 2 | MM15703 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 9.76e-04 | 64 | 97 | 4 | M26953 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.12e-03 | 30 | 97 | 3 | MM15517 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.12e-03 | 30 | 97 | 3 | M27216 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.22e-03 | 68 | 97 | 4 | M27303 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 1.28e-03 | 8 | 97 | 2 | M45025 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 1.28e-03 | 8 | 97 | 2 | M710 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 1.28e-03 | 8 | 97 | 2 | MM14753 | |
| Pathway | WP_FOLATE_METABOLISM | 1.29e-03 | 69 | 97 | 4 | M39617 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.36e-03 | 32 | 97 | 3 | MM14854 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 1.36e-03 | 32 | 97 | 3 | M165 | |
| Pathway | KEGG_PANCREATIC_CANCER | 1.36e-03 | 70 | 97 | 4 | M9726 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.48e-03 | 33 | 97 | 3 | M39503 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 1.62e-03 | 34 | 97 | 3 | MM15566 | |
| Pathway | BIOCARTA_TCAPOPTOSIS_PATHWAY | 1.63e-03 | 9 | 97 | 2 | MM1405 | |
| Pathway | BIOCARTA_TCAPOPTOSIS_PATHWAY | 1.63e-03 | 9 | 97 | 2 | M16519 | |
| Pathway | WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA | 1.63e-03 | 9 | 97 | 2 | M39670 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 1.68e-03 | 74 | 97 | 4 | M39857 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 1.93e-03 | 189 | 97 | 6 | MM14772 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 2.02e-03 | 130 | 97 | 5 | MM15455 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 2.03e-03 | 10 | 97 | 2 | MM1545 | |
| Pathway | PID_VEGF_VEGFR_PATHWAY | 2.03e-03 | 10 | 97 | 2 | M137 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 2.07e-03 | 37 | 97 | 3 | M27847 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 2.16e-03 | 132 | 97 | 5 | M724 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP49 RANBP2 LAMC1 FBXO11 MUC5B TECTA TRIM27 ADAM10 FEM1B LY6D TGFBR2 CSF1 SEC24C CCN1 TRIM28 AFP SPON1 LTBP1 ALB NUP153 | 2.23e-03 | 1475 | 97 | 20 | M19806 |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.24e-03 | 38 | 97 | 3 | MM14874 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 2.29e-03 | 264 | 97 | 7 | M9809 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.41e-03 | 39 | 97 | 3 | MM14601 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.41e-03 | 39 | 97 | 3 | M27238 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 2.48e-03 | 11 | 97 | 2 | M22033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 2.48e-03 | 11 | 97 | 2 | M47865 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 2.56e-03 | 83 | 97 | 4 | M47961 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.79e-03 | 41 | 97 | 3 | MM15538 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 2.96e-03 | 12 | 97 | 2 | M22020 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.96e-03 | 12 | 97 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.96e-03 | 12 | 97 | 2 | M47533 | |
| Pathway | KEGG_BLADDER_CANCER | 2.99e-03 | 42 | 97 | 3 | M19096 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 3.29e-03 | 89 | 97 | 4 | M47963 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.41e-03 | 44 | 97 | 3 | M27812 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | VEGFC COL3A1 PCSK5 COL5A2 VWF LAMA1 LAMC1 GRN ADAM12 ADAM10 LDLR FBLN1 EFEMP1 CSF1 CCN1 PAPPA LTBP1 FST VEGFA | 2.18e-19 | 248 | 134 | 19 | 24006456 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPC1 COL3A1 ATRN LRP12 FAT4 CRIM1 LAMA1 DNER LAMC1 GRN CD320 ADAM12 ADAM10 LRP1B LDLR LRP8 FBLN1 FBN2 EFEMP1 GLA SEC24C CCN1 TRIM28 ZDHHC6 LRP1 UHRF1 LTBP1 TWSG1 NOTCH2 NOTCH3 | 2.29e-16 | 1201 | 134 | 30 | 35696571 |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 3.30e-13 | 18 | 134 | 7 | 39040056 | |
| Pubmed | PCSK5 GPRASP1 VWF CRIM1 GRN TRIM27 FBLN1 EFEMP1 MEGF6 LRP1 LTBP1 | 1.23e-12 | 118 | 134 | 11 | 21078624 | |
| Pubmed | COL3A1 COL5A2 VWF LAMA1 LAMA3 LAMC1 ADAM10 FBLN1 EFEMP1 SPON1 LTBP1 MUC2 | 2.56e-12 | 167 | 134 | 12 | 22159717 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 6.66e-12 | 26 | 134 | 7 | 34189436 | |
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 12169628 | ||
| Pubmed | COL3A1 COL5A2 VWF LAMA1 LAMA3 LAMC1 ADAM10 FBN2 EFEMP1 MEGF6 LTBP1 | 9.18e-11 | 175 | 134 | 11 | 28071719 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.51e-10 | 21 | 134 | 6 | 21337463 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.21e-10 | 101 | 134 | 9 | 23382219 | |
| Pubmed | 1.05e-09 | 5 | 134 | 4 | 18685438 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 1.53e-09 | 14 | 134 | 5 | 17389516 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.78e-09 | 184 | 134 | 10 | 32908313 | |
| Pubmed | PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain. | 3.14e-09 | 6 | 134 | 4 | 20453200 | |
| Pubmed | 6.48e-09 | 18 | 134 | 5 | 10827173 | ||
| Pubmed | 8.89e-09 | 153 | 134 | 9 | 25037231 | ||
| Pubmed | 1.46e-08 | 8 | 134 | 4 | 10380922 | ||
| Pubmed | 1.63e-08 | 164 | 134 | 9 | 32409323 | ||
| Pubmed | 2.62e-08 | 9 | 134 | 4 | 12122015 | ||
| Pubmed | 2.62e-08 | 9 | 134 | 4 | 20005821 | ||
| Pubmed | 4.04e-08 | 50 | 134 | 6 | 23658023 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 4.59e-08 | 247 | 134 | 10 | 39238192 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 26469332 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 18367731 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 5.78e-08 | 135 | 134 | 8 | 28675934 | |
| Pubmed | 6.81e-08 | 11 | 134 | 4 | 24349473 | ||
| Pubmed | 1.06e-07 | 146 | 134 | 8 | 27068509 | ||
| Pubmed | 2.05e-07 | 14 | 134 | 4 | 15082773 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 15863833 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 22109552 | ||
| Pubmed | MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells. | 2.23e-07 | 4 | 134 | 3 | 25323858 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 21273557 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 10571240 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 15840700 | ||
| Pubmed | Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs. | 2.78e-07 | 15 | 134 | 4 | 28684544 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | VWF LAMC1 GRN VWCE TRIM27 ADAM12 FBLN1 EFEMP1 MEGF6 SLIT1 LTBP1 NOTCH2 NOTCH3 | 2.85e-07 | 560 | 134 | 13 | 21653829 |
| Pubmed | 3.41e-07 | 71 | 134 | 6 | 33541421 | ||
| Pubmed | Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development. | 3.71e-07 | 72 | 134 | 6 | 37702066 | |
| Pubmed | Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration. | 5.56e-07 | 5 | 134 | 3 | 18946489 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 16101684 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 30700132 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 12746448 | ||
| Pubmed | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. | 5.56e-07 | 5 | 134 | 3 | 18992221 | |
| Pubmed | Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. | 5.56e-07 | 5 | 134 | 3 | 23959870 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 11969289 | ||
| Pubmed | α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis. | 5.56e-07 | 5 | 134 | 3 | 30033122 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 17494763 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 8013374 | ||
| Pubmed | PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide. | 5.56e-07 | 5 | 134 | 3 | 18675252 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 7851641 | ||
| Pubmed | Chloride intracellular channel 4 is required for maturation of the cerebral collateral circulation. | 6.18e-07 | 18 | 134 | 4 | 26276819 | |
| Pubmed | 6.18e-07 | 18 | 134 | 4 | 11311202 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.45e-07 | 79 | 134 | 6 | 18757743 | |
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | VEGFC DEFB118 DNER GRN FAS ITGB6 MMP25 CD93 TGFBR2 CSF1 IL1F10 CCN1 NGFR CCR5 VEGFA | 7.35e-07 | 824 | 134 | 15 | 20237496 |
| Pubmed | Signal peptide prediction based on analysis of experimentally verified cleavage sites. | 9.32e-07 | 264 | 134 | 9 | 15340161 | |
| Pubmed | 1.06e-06 | 47 | 134 | 5 | 11208732 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.07e-06 | 86 | 134 | 6 | 28327460 | |
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 9837937 | ||
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 16478678 | ||
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 1.11e-06 | 6 | 134 | 3 | 18957219 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 1.11e-06 | 6 | 134 | 3 | 22615412 | |
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 1.11e-06 | 6 | 134 | 3 | 9506922 | |
| Pubmed | 1.18e-06 | 48 | 134 | 5 | 35247391 | ||
| Pubmed | VWC2 CHRDL2 CRIM1 LRRN1 DNER ADAM32 CD320 ADAM12 EYS IL1F10 RNFT2 TSPAN6 WFDC5 ANKRD36 ALB TCTN1 | 1.36e-06 | 985 | 134 | 16 | 12975309 | |
| Pubmed | 1.46e-06 | 22 | 134 | 4 | 35293576 | ||
| Pubmed | Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. | 1.76e-06 | 23 | 134 | 4 | 23386589 | |
| Pubmed | CYR61 (CCN1) is essential for placental development and vascular integrity. | 1.94e-06 | 7 | 134 | 3 | 12446788 | |
| Pubmed | 2.19e-06 | 152 | 134 | 7 | 19578796 | ||
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 2.50e-06 | 25 | 134 | 4 | 17170699 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 3.09e-06 | 8 | 134 | 3 | 9489770 | |
| Pubmed | 3.09e-06 | 8 | 134 | 3 | 8872465 | ||
| Pubmed | 3.09e-06 | 8 | 134 | 3 | 21757650 | ||
| Pubmed | 3.09e-06 | 8 | 134 | 3 | 9852162 | ||
| Pubmed | The role of notch signaling in the development of intrahepatic bile ducts. | 4.62e-06 | 9 | 134 | 3 | 15578515 | |
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 4.62e-06 | 9 | 134 | 3 | 7544347 | |
| Pubmed | Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. | 4.62e-06 | 9 | 134 | 3 | 21596989 | |
| Pubmed | 4.63e-06 | 63 | 134 | 5 | 23105109 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 4.64e-06 | 29 | 134 | 4 | 21402740 | |
| Pubmed | 4.96e-06 | 172 | 134 | 7 | 20628624 | ||
| Pubmed | 5.34e-06 | 30 | 134 | 4 | 32634398 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ATRN SEMA4F VWC2 FAT4 SETX LAMA1 GRN MEGF6 POP1 LRP2 PDS5A TWSG1 ALB | 5.82e-06 | 736 | 134 | 13 | 29676528 |
| Pubmed | 6.06e-06 | 332 | 134 | 9 | 37433992 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 6.11e-06 | 31 | 134 | 4 | 11431694 | |
| Pubmed | 6.58e-06 | 10 | 134 | 3 | 9034910 | ||
| Pubmed | 9.02e-06 | 11 | 134 | 3 | 12051813 | ||
| Pubmed | 9.02e-06 | 11 | 134 | 3 | 24639464 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 9.02e-06 | 11 | 134 | 3 | 21524702 | |
| Pubmed | AKAP6 NPC1 ATRN GPRASP1 VLDLR VWF CRIM1 TRIO DNER FBXO11 LRP1B WDR47 EFEMP1 CCN1 LRP1 LRP2 ANKRD36 | 9.62e-06 | 1285 | 134 | 17 | 35914814 | |
| Pubmed | 1.18e-05 | 130 | 134 | 6 | 28705898 | ||
| Pubmed | 1.20e-05 | 12 | 134 | 3 | 16750824 | ||
| Pubmed | 1.20e-05 | 12 | 134 | 3 | 32147304 | ||
| Pubmed | 1.20e-05 | 12 | 134 | 3 | 9396756 | ||
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | VWC2 CHRDL2 CRIM1 LRRN1 ITGA2B ADAM32 CD320 IL1F10 WFDC5 ALB | 1.26e-05 | 460 | 134 | 10 | 20562862 |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 1.26e-05 | 37 | 134 | 4 | 34323105 | |
| Pubmed | 1.40e-05 | 38 | 134 | 4 | 25572963 | ||
| Pubmed | 1.41e-05 | 79 | 134 | 5 | 19056482 | ||
| Pubmed | The predictive value of maternal serum AFP to PAPP-A or b-hCG ratios in spontaneous preterm birth. | 1.47e-05 | 2 | 134 | 2 | 35620869 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.47e-05 | 2 | 134 | 2 | 15963947 | |
| Pubmed | Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. | 1.47e-05 | 2 | 134 | 2 | 12594815 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 30262706 | ||
| Interaction | IGFL3 interactions | PCSK5 ATRN VLDLR LRP12 LAMA1 LAMA3 GRN LRP1B LDLR FBLN1 FBN2 LRP2 NOTCH2 NOTCH3 | 5.28e-17 | 75 | 132 | 14 | int:IGFL3 |
| Interaction | ZFP41 interactions | 3.42e-12 | 57 | 132 | 10 | int:ZFP41 | |
| Interaction | ZNF408 interactions | ATRN VLDLR LAMA1 GRN VWCE LRP1B LDLR FBN2 EFEMP1 LRP2 LTBP1 NOTCH2 NOTCH3 | 1.24e-11 | 145 | 132 | 13 | int:ZNF408 |
| Interaction | NTN5 interactions | 1.39e-10 | 24 | 132 | 7 | int:NTN5 | |
| Interaction | FBXO2 interactions | NPC1 PCSK5 ATRN LAMA1 LAMA3 SHMT1 LAMC1 GRN CD320 ADAM10 LRP1B BRAP SNED1 FBN2 LRP2 NOTCH2 NOTCH3 | 1.66e-09 | 411 | 132 | 17 | int:FBXO2 |
| Interaction | ST14 interactions | PCSK5 ATRN VLDLR CRIM1 LAMA3 ADAM10 LDLR FBLN1 FBN2 SPON1 NOTCH2 NOTCH3 | 1.19e-08 | 207 | 132 | 12 | int:ST14 |
| Interaction | MFAP5 interactions | 4.61e-08 | 52 | 132 | 7 | int:MFAP5 | |
| Interaction | HOXA1 interactions | PCSK5 VWC2 VWF CHRDL2 GRN VWCE ADAM12 FBLN1 EFEMP1 MEGF6 SLIT1 LTBP1 FST NOTCH3 | 9.32e-08 | 356 | 132 | 14 | int:HOXA1 |
| Interaction | CACNA1A interactions | 1.18e-07 | 123 | 132 | 9 | int:CACNA1A | |
| Interaction | ZNF224 interactions | 1.60e-07 | 20 | 132 | 5 | int:ZNF224 | |
| Interaction | LRPAP1 interactions | 3.07e-07 | 180 | 132 | 10 | int:LRPAP1 | |
| Interaction | SLURP1 interactions | 4.55e-07 | 144 | 132 | 9 | int:SLURP1 | |
| Interaction | FOXD4L6 interactions | 7.82e-07 | 49 | 132 | 6 | int:FOXD4L6 | |
| Interaction | ZNF517 interactions | 1.17e-06 | 29 | 132 | 5 | int:ZNF517 | |
| Interaction | ANKRD36B interactions | 2.64e-06 | 60 | 132 | 6 | int:ANKRD36B | |
| Interaction | ZNF74 interactions | 2.67e-06 | 34 | 132 | 5 | int:ZNF74 | |
| Interaction | DYRK1A interactions | NPC1 ATRN VLDLR CRIM1 LRP1B WDR47 SNED1 KMT2D EFEMP1 SEC24C CCN1 ANAPC1 LRP2 NUP153 NOTCH2 | 3.43e-06 | 552 | 132 | 15 | int:DYRK1A |
| Interaction | FBXO6 interactions | NPC1 ATRN LAMA3 LAMC1 GRN MUC5B ITGA2B ADAM10 LDLR FBLN1 FBN2 TENM4 GLA TRIM28 LRP1 LTBP1 ALB | 4.58e-06 | 717 | 132 | 17 | int:FBXO6 |
| Interaction | CLU interactions | 5.01e-06 | 245 | 132 | 10 | int:CLU | |
| Interaction | ZNF696 interactions | 5.53e-06 | 68 | 132 | 6 | int:ZNF696 | |
| Interaction | ATXN7 interactions | 7.54e-06 | 109 | 132 | 7 | int:ATXN7 | |
| Interaction | ZNF627 interactions | 7.85e-06 | 20 | 132 | 4 | int:ZNF627 | |
| Interaction | DEFB125 interactions | 7.85e-06 | 20 | 132 | 4 | int:DEFB125 | |
| Interaction | ADAM7 interactions | 8.81e-06 | 43 | 132 | 5 | int:ADAM7 | |
| Interaction | TAFA3 interactions | 1.23e-05 | 78 | 132 | 6 | int:TAFA3 | |
| Interaction | ZNF316 interactions | 1.23e-05 | 46 | 132 | 5 | int:ZNF316 | |
| Interaction | ZNF324 interactions | 1.23e-05 | 46 | 132 | 5 | int:ZNF324 | |
| Interaction | TIMP2 interactions | 1.46e-05 | 277 | 132 | 10 | int:TIMP2 | |
| Interaction | SNX17 interactions | 1.53e-05 | 81 | 132 | 6 | int:SNX17 | |
| Interaction | WNT3A interactions | 1.69e-05 | 49 | 132 | 5 | int:WNT3A | |
| Interaction | TIMP3 interactions | 2.80e-05 | 90 | 132 | 6 | int:TIMP3 | |
| Interaction | ZNF146 interactions | 2.98e-05 | 91 | 132 | 6 | int:ZNF146 | |
| Interaction | ZNF587 interactions | 3.04e-05 | 135 | 132 | 7 | int:ZNF587 | |
| Interaction | LTBP1 interactions | 3.17e-05 | 92 | 132 | 6 | int:LTBP1 | |
| Interaction | ATN1 interactions | 3.27e-05 | 187 | 132 | 8 | int:ATN1 | |
| Interaction | ZNF430 interactions | 3.68e-05 | 29 | 132 | 4 | int:ZNF430 | |
| Interaction | MAPK8IP1 interactions | 3.88e-05 | 58 | 132 | 5 | int:MAPK8IP1 | |
| Interaction | DEFA1 interactions | 5.07e-05 | 100 | 132 | 6 | int:DEFA1 | |
| Interaction | DNAJC10 interactions | 5.50e-05 | 260 | 132 | 9 | int:DNAJC10 | |
| Interaction | PLAT interactions | 5.79e-05 | 63 | 132 | 5 | int:PLAT | |
| Interaction | PDIA4 interactions | VLDLR VWF LAMC1 GRN ITGA2B EZH2 LDLR FBN2 EFEMP1 LRP2 ROS1 TCTN1 | 6.01e-05 | 468 | 132 | 12 | int:PDIA4 |
| Interaction | FBN2 interactions | 6.73e-05 | 65 | 132 | 5 | int:FBN2 | |
| Interaction | LPL interactions | 7.87e-05 | 35 | 132 | 4 | int:LPL | |
| Interaction | ZNF136 interactions | 8.80e-05 | 36 | 132 | 4 | int:ZNF136 | |
| Interaction | IGSF5 interactions | 9.48e-05 | 14 | 132 | 3 | int:IGSF5 | |
| Interaction | AGRP interactions | 9.48e-05 | 14 | 132 | 3 | int:AGRP | |
| Interaction | GREM2 interactions | 9.82e-05 | 37 | 132 | 4 | int:GREM2 | |
| Interaction | CUBN interactions | 1.18e-04 | 15 | 132 | 3 | int:CUBN | |
| Interaction | VLDLR interactions | 1.21e-04 | 39 | 132 | 4 | int:VLDLR | |
| Interaction | ZNF747 interactions | 1.34e-04 | 40 | 132 | 4 | int:ZNF747 | |
| Interaction | CCN2 interactions | 1.34e-04 | 40 | 132 | 4 | int:CCN2 | |
| Interaction | SCN3A interactions | 1.45e-04 | 16 | 132 | 3 | int:SCN3A | |
| Interaction | EGFL7 interactions | 1.51e-04 | 77 | 132 | 5 | int:EGFL7 | |
| Interaction | COL1A2 interactions | 1.61e-04 | 78 | 132 | 5 | int:COL1A2 | |
| Interaction | ADAM33 interactions | 1.71e-04 | 79 | 132 | 5 | int:ADAM33 | |
| Interaction | ZDHHC15 interactions | 1.75e-04 | 125 | 132 | 6 | int:ZDHHC15 | |
| Interaction | GLI4 interactions | 1.75e-04 | 125 | 132 | 6 | int:GLI4 | |
| Interaction | ZNF708 interactions | 2.09e-04 | 18 | 132 | 3 | int:ZNF708 | |
| Interaction | NPIPB6 interactions | 2.09e-04 | 18 | 132 | 3 | int:NPIPB6 | |
| Interaction | POU4F2 interactions | 2.15e-04 | 83 | 132 | 5 | int:POU4F2 | |
| Interaction | SLC39A7 interactions | 2.35e-04 | 187 | 132 | 7 | int:SLC39A7 | |
| Interaction | LRP1B interactions | 2.41e-04 | 85 | 132 | 5 | int:LRP1B | |
| Interaction | ZNF358 interactions | 2.46e-04 | 19 | 132 | 3 | int:ZNF358 | |
| Interaction | ZNF486 interactions | 2.53e-04 | 4 | 132 | 2 | int:ZNF486 | |
| Interaction | TRIM37 interactions | CRIM1 GRN EZH2 TRIM27 LDLR KMT2D FBN2 FAM193A CCN1 LRP1 NGFR ALB NOTCH2 | 2.57e-04 | 630 | 132 | 13 | int:TRIM37 |
| Interaction | SDF2L1 interactions | 2.76e-04 | 322 | 132 | 9 | int:SDF2L1 | |
| Interaction | KIF5C interactions | 2.83e-04 | 88 | 132 | 5 | int:KIF5C | |
| Interaction | ZNF791 interactions | 2.89e-04 | 20 | 132 | 3 | int:ZNF791 | |
| Interaction | PRG3 interactions | 2.97e-04 | 49 | 132 | 4 | int:PRG3 | |
| Interaction | ZNF460 interactions | 2.99e-04 | 138 | 132 | 6 | int:ZNF460 | |
| Interaction | DAB2 interactions | 3.23e-04 | 140 | 132 | 6 | int:DAB2 | |
| Interaction | EGFL6 interactions | 3.35e-04 | 21 | 132 | 3 | int:EGFL6 | |
| Interaction | LGALS1 interactions | 3.45e-04 | 332 | 132 | 9 | int:LGALS1 | |
| Interaction | ZNF785 interactions | 4.04e-04 | 95 | 132 | 5 | int:ZNF785 | |
| Interaction | ADAMTS1 interactions | 4.04e-04 | 95 | 132 | 5 | int:ADAMTS1 | |
| Interaction | SYT13 interactions | 4.20e-04 | 5 | 132 | 2 | int:SYT13 | |
| Interaction | AMBN interactions | 4.20e-04 | 5 | 132 | 2 | int:AMBN | |
| Interaction | NUFIP2 interactions | 4.28e-04 | 417 | 132 | 10 | int:NUFIP2 | |
| Interaction | LINGO1 interactions | 4.32e-04 | 54 | 132 | 4 | int:LINGO1 | |
| Interaction | SMOC1 interactions | 4.32e-04 | 54 | 132 | 4 | int:SMOC1 | |
| Interaction | LRP2 interactions | 5.36e-04 | 154 | 132 | 6 | int:LRP2 | |
| GeneFamily | Low density lipoprotein receptors | 1.85e-13 | 13 | 98 | 7 | 634 | |
| GeneFamily | PHD finger proteins | 3.00e-08 | 90 | 98 | 8 | 88 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.29e-05 | 27 | 98 | 4 | 47 | |
| GeneFamily | Laminin subunits | 3.28e-05 | 12 | 98 | 3 | 626 | |
| GeneFamily | VEGF family | 2.88e-04 | 5 | 98 | 2 | 1267 | |
| GeneFamily | Fibulins | 7.97e-04 | 8 | 98 | 2 | 556 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.35e-03 | 394 | 98 | 8 | 471 | |
| GeneFamily | Collagens | 1.98e-03 | 46 | 98 | 3 | 490 | |
| GeneFamily | Ankyrin repeat domain containing | 2.04e-03 | 242 | 98 | 6 | 403 | |
| GeneFamily | Ring finger proteins | 3.84e-03 | 275 | 98 | 6 | 58 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 4.20e-03 | 18 | 98 | 2 | 361 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 5.71e-03 | 21 | 98 | 2 | 89 | |
| GeneFamily | CD molecules|Mucins | 5.71e-03 | 21 | 98 | 2 | 648 | |
| GeneFamily | PWWP domain containing | 6.26e-03 | 22 | 98 | 2 | 1147 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.07e-02 | 29 | 98 | 2 | 782 | |
| Coexpression | NABA_MATRISOME | VEGFC COL3A1 PCSK5 SEMA4F VWC2 COL5A2 VWF CHRDL2 COL19A1 CRIM1 LAMA1 LAMA3 LAMC1 MUC5B ADAM32 TECTA VWCE ADAM12 ADAM10 ADAM28 MMP25 SNED1 FBLN1 EYS FBN2 EFEMP1 CSF1 IL1F10 MEGF6 CCN1 SPON1 SLIT1 PAPPA LTBP1 FST MUC2 USH2A VEGFA | 1.33e-22 | 1026 | 133 | 38 | M5889 |
| Coexpression | NABA_MATRISOME | VEGFC COL3A1 PCSK5 SEMA4F VWC2 COL5A2 VWF CHRDL2 COL19A1 CRIM1 LAMA1 LAMA3 LAMC1 MUC5B ADAM32 TECTA VWCE ADAM12 ADAM10 ADAM28 MMP25 SNED1 FBLN1 FBN2 EFEMP1 CSF1 IL1F10 MEGF6 CCN1 OTOGL SPON1 SLIT1 PAPPA LTBP1 FST MUC2 VEGFA | 7.37e-22 | 1008 | 133 | 37 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL5A2 VWF COL19A1 CRIM1 LAMA1 LAMA3 LAMC1 TECTA VWCE SNED1 FBLN1 EYS FBN2 EFEMP1 CCN1 SPON1 SLIT1 LTBP1 USH2A | 1.24e-17 | 275 | 133 | 20 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL5A2 VWF COL19A1 CRIM1 LAMA1 LAMA3 LAMC1 TECTA VWCE SNED1 FBLN1 FBN2 EFEMP1 CCN1 OTOGL SPON1 SLIT1 LTBP1 | 1.57e-16 | 270 | 133 | 19 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | VWF CRIM1 LAMA1 LAMA3 LAMC1 TECTA VWCE SNED1 FBLN1 EYS FBN2 EFEMP1 CCN1 SPON1 SLIT1 LTBP1 USH2A | 2.04e-16 | 196 | 133 | 17 | M3008 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | VWF CRIM1 LAMA1 LAMA3 LAMC1 TECTA VWCE SNED1 FBLN1 FBN2 EFEMP1 CCN1 OTOGL SPON1 SLIT1 LTBP1 | 2.85e-15 | 191 | 133 | 16 | MM17059 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | VEGFC COL3A1 COL5A2 LAMA1 LAMA3 LAMC1 FAS ADAM12 FBLN1 FBN2 CCN1 LRP1 NOTCH2 VEGFA | 1.98e-12 | 200 | 133 | 14 | M5930 |
| Coexpression | HALLMARK_UV_RESPONSE_DN | COL3A1 ATRN COL5A2 VLDLR LAMC1 LDLR TGFBR2 EFEMP1 CCN1 LTBP1 NOTCH2 | 1.99e-10 | 144 | 133 | 11 | M5942 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | VEGFC PCSK5 SEMA4F VWC2 CHRDL2 MUC5B ADAM32 ADAM12 ADAM10 ADAM28 MMP25 CSF1 IL1F10 MEGF6 PAPPA FST MUC2 VEGFA | 3.89e-08 | 738 | 133 | 18 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | VEGFC PCSK5 SEMA4F VWC2 CHRDL2 MUC5B ADAM32 ADAM12 ADAM10 ADAM28 MMP25 CSF1 IL1F10 MEGF6 PAPPA FST MUC2 VEGFA | 5.06e-08 | 751 | 133 | 18 | M5885 |
| Coexpression | BMI1_DN_MEL18_DN.V1_UP | 5.75e-08 | 145 | 133 | 9 | M2779 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | VEGFC COL3A1 COL5A2 CHRDL2 CRIM1 LAMC1 LDLR ITGB6 FBLN1 EFEMP1 TENM4 CSF1 CCN1 OTOGL NGFR PAPPA FST NOTCH3 | 6.93e-08 | 767 | 133 | 18 | M39209 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | COL3A1 PCSK5 COL5A2 CRIM1 LMTK2 LDLR FBLN1 FBN2 EFEMP1 CSF1 CCN1 ANKRD36 | 2.80e-07 | 355 | 133 | 12 | M45758 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL5A2 VWF LAMC1 ADAM28 CD93 SNED1 FBLN1 EFEMP1 CSF1 LRP1 PAPPA FST NOTCH3 | 3.06e-07 | 505 | 133 | 14 | M39167 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | VEGFC ATRN COL5A2 VLDLR RANBP2 SETX CRIM1 TRIO LAMC1 CCND1 ADAM10 LDLR TSPAN5 TGFBR2 FAM193A CCN1 PDS5A NUP153 | 3.50e-07 | 856 | 133 | 18 | M4500 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | COL3A1 COL5A2 LAMA1 LAMC1 SNED1 FBLN1 FBN2 CCN1 SPON1 FST NOTCH2 NOTCH3 | 6.61e-07 | 385 | 133 | 12 | M39264 |
| Coexpression | BMI1_DN.V1_UP | 8.77e-07 | 147 | 133 | 8 | M2782 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.53e-06 | 6 | 133 | 3 | M48000 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | NPC1 ATRN LRP12 LAMC1 GRN LDLR SNED1 TENM4 GLA LRP1 TWSG1 TCTN1 | 3.91e-06 | 457 | 133 | 12 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | NPC1 ATRN LRP12 LAMC1 GRN LDLR SNED1 TENM4 GLA LRP1 TWSG1 TCTN1 | 5.20e-06 | 470 | 133 | 12 | MM1053 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 5.21e-06 | 23 | 133 | 4 | M48001 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 6.06e-06 | 322 | 133 | 10 | M39060 | |
| Coexpression | GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN | 7.20e-06 | 195 | 133 | 8 | M9706 | |
| Coexpression | MEL18_DN.V1_UP | 7.94e-06 | 141 | 133 | 7 | M2784 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN | 8.35e-06 | 199 | 133 | 8 | M5151 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 1.16e-05 | 99 | 133 | 6 | M39152 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.31e-05 | 352 | 133 | 10 | M17471 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | 1.38e-05 | 354 | 133 | 10 | M39061 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | COL5A2 VWF LAMC1 CD320 TSPAN5 LRP8 MMP25 CD93 MEGF6 CCN1 TSPAN6 | 1.59e-05 | 440 | 133 | 11 | M39039 |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 2.04e-05 | 32 | 133 | 4 | M308 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 2.38e-05 | 167 | 133 | 7 | M2395 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 3.10e-05 | 71 | 133 | 5 | M2948 | |
| Coexpression | ZHU_CMV_ALL_DN | 3.31e-05 | 119 | 133 | 6 | M14555 | |
| Coexpression | LU_EZH2_TARGETS_DN | 3.91e-05 | 400 | 133 | 10 | M2140 | |
| Coexpression | DANG_REGULATED_BY_MYC_DN | 4.43e-05 | 251 | 133 | 8 | M2310 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL3A1 COL5A2 TRIO LAMC1 ADAM12 TSPAN5 CCN1 SPON1 PAPPA LTBP1 TWSG1 NOTCH2 NOTCH3 | 4.51e-05 | 681 | 133 | 13 | M39175 |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 4.52e-05 | 407 | 133 | 10 | M19541 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 4.58e-05 | 185 | 133 | 7 | MM1072 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | PCSK5 SEMA4F LAMA3 LAMC1 ADAM32 TSPAN5 LRP8 CEP68 FANCB RNFT2 ANAPC1 TRIM28 MINAR1 CLUL1 NOTCH3 | 4.84e-05 | 891 | 133 | 15 | M45033 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.03e-05 | 40 | 133 | 4 | M5887 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 5.23e-05 | 257 | 133 | 8 | M13867 | |
| Coexpression | TSUNODA_CISPLATIN_RESISTANCE_UP | 5.56e-05 | 15 | 133 | 3 | M10202 | |
| Coexpression | LEE_BMP2_TARGETS_DN | PCSK5 LRP12 SHMT1 SMYD5 EZH2 ADAM12 LDLR FANCB GLA POP1 UHRF1 PDS5A FST NUP153 VEGFA | 5.70e-05 | 904 | 133 | 15 | M2325 |
| Coexpression | BOQUEST_STEM_CELL_UP | 5.82e-05 | 261 | 133 | 8 | M1834 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 5.99e-05 | 193 | 133 | 7 | M39321 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP | COL3A1 LRP12 VWF CHRDL2 LDLR EFEMP1 CSF1 SPON1 PAPPA TCTN1 VEGFA | 6.85e-05 | 517 | 133 | 11 | M7140 |
| Coexpression | PDGF_UP.V1_DN | 6.98e-05 | 136 | 133 | 6 | M2832 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 7.04e-05 | 198 | 133 | 7 | MM17083 | |
| Coexpression | LEE_BMP2_TARGETS_DN | PCSK5 LRP12 SHMT1 SMYD5 EZH2 ADAM12 LDLR FANCB GLA POP1 UHRF1 PDS5A FST NUP153 VEGFA | 7.11e-05 | 922 | 133 | 15 | MM1068 |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 7.27e-05 | 137 | 133 | 6 | M40313 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN | 7.49e-05 | 200 | 133 | 7 | M3525 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN | 7.49e-05 | 200 | 133 | 7 | M9950 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 7.49e-05 | 200 | 133 | 7 | M6583 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 9.29e-05 | 207 | 133 | 7 | M14566 | |
| Coexpression | AMIT_EGF_RESPONSE_60_HELA | 9.54e-05 | 47 | 133 | 4 | M10797 | |
| Coexpression | PECE_MAMMARY_STEM_CELL_DN | 9.58e-05 | 144 | 133 | 6 | M2535 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_6HR_DN | 9.86e-05 | 18 | 133 | 3 | M659 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 1.05e-04 | 284 | 133 | 8 | M16975 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | VWC2 FAT4 COL19A1 LAMA1 CCND1 MMP25 TGFBR2 SNED1 TENM4 CCN1 SPON1 LRP2 UHRF1 PAPPA MINAR1 FST | 1.13e-04 | 1074 | 133 | 16 | M1941 |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 1.17e-04 | 19 | 133 | 3 | M15125 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN | ATRN CRIM1 SHMT1 CCND1 ADAM12 ADAM10 LRP8 FEM1B TGFBR2 EFEMP1 CCN1 RNFT2 | 1.17e-04 | 647 | 133 | 12 | M10351 |
| Coexpression | KAYO_CALORIE_RESTRICTION_MUSCLE_UP | 1.19e-04 | 94 | 133 | 5 | M7013 | |
| Coexpression | MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN | 1.37e-04 | 20 | 133 | 3 | M1991 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 1.39e-04 | 296 | 133 | 8 | M41675 | |
| Coexpression | PATIL_LIVER_CANCER | ATRN COL5A2 VWF TRIO LMTK2 GRN EZH2 TSPAN5 GLA TRIM28 AFP NOTCH3 | 1.41e-04 | 660 | 133 | 12 | M1195 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 1.53e-04 | 300 | 133 | 8 | M39059 | |
| Coexpression | FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL | 1.88e-04 | 232 | 133 | 7 | M41718 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | CRIM1 LMTK2 SHMT1 CCND1 LY6D TGFBR2 FBLN1 TENM4 CCN1 SPON1 PDS5A TWSG1 | 2.12e-04 | 690 | 133 | 12 | M12224 |
| Coexpression | NABA_ECM_REGULATORS | 2.20e-04 | 238 | 133 | 7 | M3468 | |
| Coexpression | JEON_SMAD6_TARGETS_UP | 2.39e-04 | 24 | 133 | 3 | M4592 | |
| Coexpression | NABA_ECM_REGULATORS | 2.43e-04 | 242 | 133 | 7 | MM17062 | |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 2.43e-04 | 242 | 133 | 7 | M2128 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | SEMA4F CHRDL2 DNER LAMA3 ADAM12 FBN2 CSF1 DPF3 SPON1 SLIT1 TSPAN6 NGFR LRP2 PAPPA NOTCH2 | 2.51e-04 | 1035 | 133 | 15 | M9898 |
| Coexpression | LEI_MYB_TARGETS | 2.52e-04 | 323 | 133 | 8 | M863 | |
| Coexpression | WNT_UP.V1_DN | 2.52e-04 | 172 | 133 | 6 | M2689 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 2.63e-04 | 325 | 133 | 8 | M39053 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 2.68e-04 | 174 | 133 | 6 | M45676 | |
| Coexpression | NOJIMA_SFRP2_TARGETS_DN | 3.05e-04 | 26 | 133 | 3 | M2733 | |
| Coexpression | HAN_SATB1_TARGETS_UP | 3.30e-04 | 425 | 133 | 9 | M9639 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.32e-04 | 117 | 133 | 5 | M39300 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 3.35e-04 | 337 | 133 | 8 | MM16606 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 3.38e-04 | 65 | 133 | 4 | M15542 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.41e-04 | 338 | 133 | 8 | MM17064 | |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN | 3.51e-04 | 183 | 133 | 6 | M7627 | |
| Coexpression | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP | 3.58e-04 | 258 | 133 | 7 | M4680 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.76e-04 | 343 | 133 | 8 | M5883 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 3.78e-04 | 433 | 133 | 9 | M2240 | |
| Coexpression | ESC_J1_UP_LATE.V1_UP | 3.83e-04 | 186 | 133 | 6 | M2768 | |
| Coexpression | LU_AGING_BRAIN_UP | 4.02e-04 | 263 | 133 | 7 | M5547 | |
| Coexpression | SAUL_SEN_MAYO | 4.17e-04 | 123 | 133 | 5 | MM16098 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.24e-04 | 29 | 133 | 3 | MM17055 | |
| Coexpression | SAUL_SEN_MAYO | 4.33e-04 | 124 | 133 | 5 | M45803 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP | 4.50e-04 | 125 | 133 | 5 | M15672 | |
| Coexpression | AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP | 4.66e-04 | 126 | 133 | 5 | M2309 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 4.79e-04 | 194 | 133 | 6 | M39122 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 4.85e-04 | 546 | 133 | 10 | M3837 | |
| Coexpression | GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN | 4.92e-04 | 195 | 133 | 6 | M10022 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | COL3A1 COL5A2 CRIM1 FEM1B FBLN1 KMT2D CCN1 OTOGL PDS5A NOTCH3 | 4.99e-04 | 548 | 133 | 10 | M16859 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 USP49 GPRASP1 LRP12 CRIM1 DNER LAMA3 VWCE LRP1B ANKRD36B MEGF6 PAPPA ANKRD36 BRD1 MUC2 | 5.04e-04 | 1106 | 133 | 15 | M39071 |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 5.13e-04 | 274 | 133 | 7 | M289 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | VEGFC COL3A1 COL5A2 LAMC1 CCND1 ADAM12 SNED1 FBLN1 EFEMP1 CSF1 CCN1 SPON1 TSPAN6 LRP1 NOTCH3 VEGFA | 2.20e-08 | 455 | 131 | 16 | GSM777055_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | VEGFC COL3A1 COL5A2 LAMC1 CCND1 ADAM12 FBLN1 EFEMP1 CSF1 CCN1 SPON1 TSPAN6 LRP1 LTBP1 NOTCH3 VEGFA | 3.07e-08 | 466 | 131 | 16 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 6.46e-07 | 207 | 131 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.35e-06 | 97 | 131 | 7 | GSM777043_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | COL3A1 CHRDL2 LRRN1 LAMA1 DNER SLC34A2 ADAM12 LRP1B LMX1A AFP SPON1 SLIT1 LRP2 ALB | 2.48e-06 | 497 | 131 | 14 | PCBC_EB_fibroblast_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | AKAP6 COL3A1 CHRDL2 LRRN1 LAMA1 DNER SLC34A2 ADAM12 LRP1B ITGB6 TENM4 LMX1A AFP SPON1 SLIT1 LRP2 PAPPA MINAR1 ALB CLUL1 | 2.65e-06 | 986 | 131 | 20 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | COL3A1 LAMA1 DNER SLC34A2 ADAM12 TENM4 LMX1A AFP SPON1 SLIT1 LRP2 PRR9 PAPPA | 2.89e-06 | 433 | 131 | 13 | Arv_EB-LF_1000_K4 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 3.01e-06 | 65 | 131 | 6 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 3.49e-06 | 146 | 131 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | VLDLR CRIM1 LAMA1 LAMC1 CCND1 FBN2 TENM4 LRP2 UHRF1 LTBP1 NOTCH2 SP140 | 6.80e-06 | 398 | 131 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | COL3A1 LAMA1 TSPAN5 FBLN1 FBN2 EFEMP1 TENM4 CCN1 LRP1 UHRF1 LTBP1 | 7.97e-06 | 337 | 131 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | COL3A1 LAMA1 TSPAN5 FBN2 EFEMP1 TENM4 CCN1 DPF3 LRP1 UHRF1 LTBP1 VEGFA | 1.11e-05 | 418 | 131 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | COL3A1 FAT4 CHRDL2 LRRN1 LAMA1 DNER SLC34A2 ADAM12 LRP1B ITGB6 TENM4 LMX1A AFP SPON1 SLIT1 LRP2 PAPPA ALB CLUL1 | 1.13e-05 | 994 | 131 | 19 | PCBC_EB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | VEGFC SEMA4F FAT4 SETX LRRN1 DNER LAMC1 ADAM12 CD93 FBN2 TENM4 FAM193A ANAPC1 AFP LTBP1 TWSG1 VEGFA | 1.18e-05 | 818 | 131 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | COL3A1 VLDLR LAMA1 FBN2 EFEMP1 TENM4 GLA CCN1 LRP1 UHRF1 LTBP1 | 1.26e-05 | 354 | 131 | 11 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | VEGFC CRIM1 LRRN1 LAMC1 CCND1 FBN2 TENM4 UHRF1 LTBP1 NOTCH2 SP140 | 1.90e-05 | 370 | 131 | 11 | gudmap_kidney_P3_CapMes_Crym_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | VEGFC COL3A1 VLDLR CRIM1 GRN FAS TGFBR2 FBLN1 EFEMP1 CSF1 LRP1 LRP2 TWSG1 ADGRE1 FST SP140 | 2.46e-05 | 778 | 131 | 16 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | COL3A1 FAT4 LRRN1 LAMA1 TSPAN5 FBN2 TENM4 CCN1 LRP1 LTBP1 FST | 2.94e-05 | 388 | 131 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | VEGFC COL3A1 PCSK5 ATRN COL5A2 FAT4 VWF LRRN1 LRP8 SNED1 FBN2 EFEMP1 TENM4 FAM193A CSF1 SLIT1 NGFR PAPPA LTBP1 TWSG1 | 3.09e-05 | 1166 | 131 | 20 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | NPC1 FAT4 LRRN1 LAMA1 TSPAN5 FBN2 EFEMP1 TENM4 GLA CCN1 DPF3 LRP1 UHRF1 ALB FST VEGFA | 3.30e-05 | 797 | 131 | 16 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.64e-05 | 327 | 131 | 10 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | VEGFC COL3A1 VLDLR CRIM1 FAS EFEMP1 CSF1 LRP1 LRP2 ADGRE1 FST | 4.64e-05 | 408 | 131 | 11 | gudmap_kidney_adult_RenalCapsule_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL3A1 VLDLR FAT4 LRRN1 LAMA1 FBN2 EFEMP1 TENM4 GLA CCN1 DPF3 LRP1 UHRF1 LTBP1 FST VEGFA | 5.42e-05 | 831 | 131 | 16 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | VEGFC COL5A2 LRP12 SETX VWF LRRN1 FAS ADAM12 CD93 FBLN1 FBN2 TENM4 CCN1 ANAPC1 LTBP1 VEGFA | 5.90e-05 | 837 | 131 | 16 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | AKAP6 COL3A1 COL5A2 ADAM12 LRP1B ITGB6 LMX1A DPF3 AFP SLIT1 PAPPA ALB | 6.16e-05 | 498 | 131 | 12 | PCBC_ratio_EB_vs_SC_500 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 6.87e-05 | 284 | 131 | 9 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 7.79e-05 | 166 | 131 | 7 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | COL3A1 COL5A2 LAMC1 SNED1 FBLN1 EFEMP1 CSF1 CCN1 LRP1 LTBP1 FST | 8.58e-05 | 437 | 131 | 11 | GSM777046_500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.72e-05 | 293 | 131 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | COL3A1 COL5A2 LAMC1 CCND1 FBLN1 EFEMP1 CSF1 CCN1 SPON1 LRP1 LTBP1 | 1.01e-04 | 445 | 131 | 11 | GSM777043_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.01e-04 | 120 | 131 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | COL3A1 COL5A2 CRIM1 LAMC1 EFEMP1 CSF1 CCN1 TSPAN6 LRP1 FST NOTCH3 | 1.18e-04 | 453 | 131 | 11 | GSM777067_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | NPC1 COL3A1 FAT4 LRRN1 LAMA1 TSPAN5 FBLN1 FBN2 TENM4 CCN1 DPF3 LRP1 FST SP140 VEGFA | 1.21e-04 | 797 | 131 | 15 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | RANBP2 LRRN1 LAMA1 EZH2 ADAM10 LDLR LRP8 WDR47 FAM193A RNFT2 SPON1 LRP2 UHRF1 PDS5A PAPPA DHX32 FST | 1.26e-04 | 989 | 131 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.34e-04 | 310 | 131 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | VEGFC COL3A1 COL5A2 FAT4 CRIM1 DNER ADAM12 LRP1B FBN2 TENM4 LMX1A AFP SPON1 SLIT1 LRP2 PAPPA ALB CLUL1 | 1.35e-04 | 1094 | 131 | 18 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | SEMA4F VWC2 FAT4 SETX TRIO LAMA3 LAMC1 CD93 EFEMP1 TENM4 FAM193A ANAPC1 AFP TWSG1 VEGFA | 1.37e-04 | 806 | 131 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | VLDLR CRIM1 LAMA1 LAMC1 CCND1 ITGB6 CD93 EFEMP1 CCN1 AFP LRP2 LTBP1 ALB NOTCH2 NOTCH3 SP140 | 1.46e-04 | 905 | 131 | 16 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | VEGFC COL3A1 COL5A2 CRIM1 LAMC1 FAS ADAM12 SNED1 FBLN1 CSF1 MEGF6 LRP1 PAPPA TWSG1 CLUL1 | 1.52e-04 | 814 | 131 | 15 | JC_fibro_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL3A1 LAMA1 TSPAN5 FBLN1 FBN2 EFEMP1 TENM4 GLA CCN1 DPF3 LRP1 UHRF1 LTBP1 NOTCH2 VEGFA | 1.81e-04 | 827 | 131 | 15 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#2 | 1.88e-04 | 255 | 131 | 8 | Arv_EB-LF_500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.11e-04 | 195 | 131 | 7 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | VEGFC FAT4 VWF CRIM1 TRIO LAMC1 GRN CCND1 TSPAN5 CD93 TGFBR2 SNED1 EFEMP1 CSF1 CCN1 SP140 | 2.14e-04 | 936 | 131 | 16 | JC_hmvEC_2500_K1 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.20e-04 | 261 | 131 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | USP49 COL5A2 LRP12 TMEM74 LAMA1 ANKRD36C FBN2 EFEMP1 MEGF6 CCN1 LMX1A SPON1 NGFR LRP2 PPIP5K1 DHX32 LTBP1 ANKRD36 TWSG1 FST NOTCH2 | 2.48e-04 | 1466 | 131 | 21 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL3A1 LAMA1 DNER SLC34A2 ADAM12 TENM4 CCN1 LMX1A AFP SPON1 SLIT1 LRP2 PAPPA MINAR1 ALB CLUL1 | 2.56e-04 | 951 | 131 | 16 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | COL3A1 LRRN1 LAMA1 DNER ADAM12 LMX1A AFP SPON1 SLIT1 LRP2 ALB | 2.58e-04 | 496 | 131 | 11 | PCBC_EB_500 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | COL3A1 CHRDL2 LRRN1 DNER SLC34A2 ADAM12 ITGB6 AFP SLIT1 LRP2 PAPPA | 2.58e-04 | 496 | 131 | 11 | Arv_EB-LF_500 |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | NPC1 COL3A1 PCSK5 COL5A2 DNER LAMA3 LAMC1 GRN LDLR ITGB6 TGFBR2 CCN1 SLIT1 PAPPA | 2.60e-04 | 761 | 131 | 14 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#1 | VEGFC PCSK5 COL5A2 VLDLR TRIO DNER ADAM32 CD320 ADAM12 CD93 TGFBR2 FBN2 SLIT1 | 2.70e-04 | 672 | 131 | 13 | JC_iEC_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 3.00e-04 | 423 | 131 | 10 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | COL3A1 LAMA1 ADAM12 TSPAN5 FBLN1 FBN2 TENM4 CCN1 DPF3 LRP1 UHRF1 PAPPA NOTCH2 VEGFA | 3.05e-04 | 773 | 131 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 3.17e-04 | 148 | 131 | 6 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.17e-04 | 148 | 131 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | VEGFC COL3A1 CRIM1 LAMA1 LAMC1 CCND1 FAS ADAM12 TGFBR2 SNED1 EFEMP1 CSF1 CCN1 LRP1 PAPPA FST | 3.38e-04 | 975 | 131 | 16 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | COL3A1 FAT4 LRRN1 LAMA1 TSPAN5 FBN2 TENM4 CCN1 DPF3 LRP1 LTBP1 FST NOTCH2 VEGFA | 3.47e-04 | 783 | 131 | 14 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | VLDLR CRIM1 LAMA1 LAMC1 CCND1 EZH2 FBLN1 FBN2 TENM4 LRP2 UHRF1 LTBP1 NOTCH2 SP140 | 3.47e-04 | 783 | 131 | 14 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL3A1 CHRDL2 LRRN1 LAMA1 DNER SLC34A2 ADAM12 ITGB6 TENM4 LMX1A AFP SPON1 SLIT1 LRP2 PRR9 PAPPA | 3.61e-04 | 981 | 131 | 16 | Arv_EB-LF_1000 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.62e-04 | 281 | 131 | 8 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.62e-04 | 281 | 131 | 8 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | EB bone marrow_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | COL3A1 PCSK5 VLDLR SLC34A2 ADAM12 ITGB6 TSPAN5 CSF1 LRP2 ALB | 4.54e-04 | 446 | 131 | 10 | PCBC_ratio_EB bone marrow_vs_EB blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SEMA4F FAT4 SETX LRRN1 TRIO DNER LAMA3 LAMC1 ADAM10 EFEMP1 TENM4 FAM193A TWSG1 FST | 4.63e-04 | 806 | 131 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_200 | 5.12e-04 | 162 | 131 | 6 | gudmap_developingKidney_e11.5_ureteric bud_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 5.40e-04 | 456 | 131 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 5.64e-04 | 165 | 131 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 5.64e-04 | 165 | 131 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.53e-04 | 385 | 131 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 6.60e-04 | 64 | 131 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | NPC1 COL3A1 FAT4 LRRN1 LAMA1 TSPAN5 FBN2 TENM4 CCN1 LRP1 LTBP1 FST VEGFA | 6.69e-04 | 740 | 131 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | COL3A1 PCSK5 COL5A2 LRP12 FAT4 VWF LRRN1 ITGA2B SNED1 FBN2 EFEMP1 TENM4 FAM193A CSF1 DPF3 SLIT1 NGFR | 7.05e-04 | 1148 | 131 | 17 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.05e-04 | 311 | 131 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 7.68e-04 | 175 | 131 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | COL3A1 LRRN1 LAMA1 TSPAN5 FBLN1 TENM4 GLA CCN1 DPF3 LRP1 UHRF1 LTBP1 FST VEGFA | 8.53e-04 | 858 | 131 | 14 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.33e-04 | 250 | 131 | 7 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | COL3A1 PCSK5 LAMA1 ADAM12 TSPAN5 FBLN1 FBN2 TENM4 CCN1 LRP1 UHRF1 NOTCH2 VEGFA | 9.41e-04 | 768 | 131 | 13 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 9.64e-04 | 122 | 131 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | USP49 LRP12 TMEM74 LAMA1 CCND1 ANKRD36C TSPAN5 EFEMP1 LMX1A SPON1 NGFR LRP2 PPIP5K1 DHX32 ANKRD36 NOTCH2 | 9.67e-04 | 1075 | 131 | 16 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | COL3A1 VWC2 VLDLR FAT4 CCND1 FBLN1 FBN2 ANAPC1 SPON1 PAPPA LTBP1 TWSG1 FST | 9.87e-04 | 772 | 131 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#1_top-relative-expression-ranked_500 | 9.99e-04 | 32 | 131 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_100 | 1.03e-03 | 8 | 131 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k2 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | 1.04e-03 | 411 | 131 | 9 | gudmap_developingKidney_e12.5_renal vesicle_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 1.04e-03 | 411 | 131 | 9 | GSM538239_500 | |
| CoexpressionAtlas | ovary | 1.07e-03 | 125 | 131 | 5 | ovary | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL5A2 VLDLR LRP12 VWF LAMA1 SLC34A2 ADAM28 FBN2 TENM4 MEGF6 LMX1A LTBP1 CLUL1 FST VEGFA | 1.08e-03 | 982 | 131 | 15 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 1.13e-03 | 416 | 131 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 1.15e-03 | 127 | 131 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#4_top-relative-expression-ranked_500 | 1.19e-03 | 34 | 131 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | COL3A1 LRRN1 LAMA1 DNER ADAM12 LRP1B TENM4 LMX1A AFP SPON1 SLIT1 LRP2 PAPPA ALB CLUL1 | 1.20e-03 | 992 | 131 | 15 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | AKAP6 VEGFC COL3A1 COL5A2 FAT4 ADAM12 LRP1B ITGB6 LMX1A DPF3 AFP SLIT1 PAPPA ALB CLUL1 | 1.22e-03 | 994 | 131 | 15 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 1.22e-03 | 421 | 131 | 9 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | VEGFC COL3A1 PCSK5 SEMA4F VWC2 COL5A2 FAT4 LRRN1 TRIO SNED1 FBN2 EFEMP1 PAPPA | 1.23e-03 | 791 | 131 | 13 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_100 | 1.39e-03 | 78 | 131 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_100 | 1.39e-03 | 78 | 131 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.52e-03 | 80 | 131 | 4 | GSM605856_100 | |
| CoexpressionAtlas | BM Top 100 - vulva | 1.67e-03 | 82 | 131 | 4 | BM Top 100 - vulva | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#3 | 1.69e-03 | 204 | 131 | 6 | ratio_EB_vs_SC_500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 1.70e-03 | 357 | 131 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL19A1 ABCA12 LAMA1 MUC5B LRP1B FBN2 TENM4 OTOGL LRP2 ROS1 USH2A | 4.16e-13 | 184 | 134 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL19A1 ABCA12 LAMA1 MUC5B LRP1B FBN2 TENM4 OTOGL LRP2 ROS1 USH2A | 4.16e-13 | 184 | 134 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL19A1 ABCA12 LAMA1 MUC5B LRP1B FBN2 TENM4 OTOGL LRP2 ROS1 USH2A | 4.16e-13 | 184 | 134 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | COL3A1 COL5A2 LAMC1 ADAM12 SNED1 FBLN1 EFEMP1 TENM4 LMX1A LRP1 PAPPA NOTCH2 | 7.80e-13 | 194 | 134 | 12 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL5A2 VLDLR LAMC1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 LTBP1 TWSG1 | 1.58e-11 | 191 | 134 | 11 | 997abf0cc5873bed0372c4a333ed307fa72774d2 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 PCSK5 COL5A2 FAT4 LAMC1 SNED1 FBLN1 EFEMP1 SPON1 LRP1 LTBP1 | 1.97e-11 | 195 | 134 | 11 | f54bc4454270ff06e85596f98199372b50d0179f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL5A2 FAT4 LAMC1 ADAM12 SNED1 EFEMP1 CSF1 CCN1 SPON1 LTBP1 | 2.20e-11 | 197 | 134 | 11 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | VEGFC COL3A1 COL5A2 ADAM12 SNED1 FBLN1 TENM4 CCN1 SPON1 PAPPA LTBP1 | 2.20e-11 | 197 | 134 | 11 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL5A2 FAT4 LAMC1 ADAM12 SNED1 EFEMP1 CSF1 CCN1 SPON1 LTBP1 | 2.20e-11 | 197 | 134 | 11 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 PCSK5 COL5A2 VLDLR LAMC1 TGFBR2 FBLN1 EFEMP1 LRP1 LTBP1 TWSG1 | 2.33e-11 | 198 | 134 | 11 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | VEGFC COL3A1 VWC2 COL5A2 FAT4 LAMC1 ADAM28 SNED1 CSF1 LRP1 VEGFA | 2.33e-11 | 198 | 134 | 11 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL3A1 COL5A2 CHRDL2 LDLR FBLN1 CCN1 LRP1 PAPPA LTBP1 FST VEGFA | 2.46e-11 | 199 | 134 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL5A2 VLDLR TRIO VWCE ADAM12 TENM4 NGFR PAPPA NOTCH2 | 1.65e-10 | 177 | 134 | 10 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.13e-10 | 129 | 134 | 9 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL5A2 LAMC1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 LTBP1 TWSG1 | 2.16e-10 | 182 | 134 | 10 | c557de6ccd327c46e0a5423cd9936d78e0abae5f |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL5A2 LAMC1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 LTBP1 TWSG1 | 2.16e-10 | 182 | 134 | 10 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 |
| ToppCell | Basal|World / shred by cell class for mouse tongue | CRIM1 LAMA3 SHMT1 CCND1 TGFBR2 EFEMP1 MEGF6 SLIT1 PAPPA LTBP1 | 2.28e-10 | 183 | 134 | 10 | c6729a207526ff4aa48176207b9353176f631fea |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A2 LAMC1 SNED1 FBLN1 EFEMP1 LMX1A SPON1 LRP1 LTBP1 | 3.13e-10 | 189 | 134 | 10 | d531399749409d614adca13d181830c6e3287508 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL3A1 COL5A2 CHRDL2 ADAM12 TSPAN5 FBLN1 SPON1 LRP1 PAPPA VEGFA | 3.29e-10 | 190 | 134 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL5A2 LAMC1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 TWSG1 VEGFA | 3.47e-10 | 191 | 134 | 10 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-10 | 191 | 134 | 10 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-10 | 191 | 134 | 10 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-10 | 191 | 134 | 10 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL5A2 LAMC1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 LTBP1 TWSG1 | 3.65e-10 | 192 | 134 | 10 | 8df15085b35b86f39debd933284cb703c5dd63c2 |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A2 LAMC1 SNED1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 TWSG1 | 3.84e-10 | 193 | 134 | 10 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A2 LAMC1 SNED1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 TWSG1 | 3.84e-10 | 193 | 134 | 10 | 30481fb01c7acf85beae10213f038da86bed6777 |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 PCSK5 COL5A2 VLDLR LAMC1 FBLN1 EFEMP1 SPON1 LTBP1 TWSG1 | 4.25e-10 | 195 | 134 | 10 | 69a29d03e664b72f32d41876510c62345c3aed31 |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.25e-10 | 195 | 134 | 10 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 PCSK5 COL5A2 VLDLR LAMC1 FBLN1 EFEMP1 SPON1 LTBP1 TWSG1 | 4.25e-10 | 195 | 134 | 10 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 PCSK5 COL5A2 VLDLR LAMC1 FBLN1 EFEMP1 SPON1 LTBP1 TWSG1 | 4.25e-10 | 195 | 134 | 10 | 9cef6f18664518060af7c192310dddce6d70345a |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-10 | 196 | 134 | 10 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL5A2 FAT4 LAMC1 ADAM12 SNED1 CSF1 CCN1 SPON1 NOTCH2 | 4.93e-10 | 198 | 134 | 10 | a860246bcea847249a78fd2e86ed8e04371060db |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | COL3A1 COL5A2 LAMC1 SNED1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 LTBP1 | 5.17e-10 | 199 | 134 | 10 | 13ff7409e200a0b46cdb7924d15ef33639693622 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.43e-10 | 200 | 134 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL3A1 COL5A2 LAMC1 SNED1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 PAPPA | 5.43e-10 | 200 | 134 | 10 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL5A2 FAT4 LAMC1 SNED1 FBLN1 EFEMP1 SPON1 LRP1 LTBP1 | 5.43e-10 | 200 | 134 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-10 | 200 | 134 | 10 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL3A1 COL5A2 LAMC1 SNED1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 PAPPA | 5.43e-10 | 200 | 134 | 10 | 1c10597edd532bf172ca09870a937d35e2585081 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL5A2 LAMC1 ADAM28 FBLN1 FBN2 EFEMP1 CCN1 LRP1 TWSG1 | 5.43e-10 | 200 | 134 | 10 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL3A1 COL5A2 LAMC1 SNED1 FBLN1 EFEMP1 CCN1 SPON1 LRP1 PAPPA | 5.43e-10 | 200 | 134 | 10 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-09 | 160 | 134 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-09 | 160 | 134 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-09 | 172 | 134 | 9 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-09 | 173 | 134 | 9 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-09 | 176 | 134 | 9 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-09 | 176 | 134 | 9 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-09 | 183 | 134 | 9 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 4.94e-09 | 184 | 134 | 9 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-09 | 184 | 134 | 9 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.18e-09 | 185 | 134 | 9 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-09 | 189 | 134 | 9 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-09 | 189 | 134 | 9 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-09 | 189 | 134 | 9 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.17e-09 | 192 | 134 | 9 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.17e-09 | 192 | 134 | 9 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | droplet-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.17e-09 | 192 | 134 | 9 | 086b47f87283cd41139cd56686011f8b5821b0da | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.17e-09 | 192 | 134 | 9 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.17e-09 | 192 | 134 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-09 | 193 | 134 | 9 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.50e-09 | 193 | 134 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-09 | 193 | 134 | 9 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.50e-09 | 193 | 134 | 9 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-09 | 193 | 134 | 9 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.50e-09 | 193 | 134 | 9 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-09 | 194 | 134 | 9 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-09 | 194 | 134 | 9 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-09 | 194 | 134 | 9 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 8.20e-09 | 195 | 134 | 9 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-09 | 195 | 134 | 9 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-09 | 195 | 134 | 9 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 8.58e-09 | 196 | 134 | 9 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.58e-09 | 196 | 134 | 9 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-09 | 196 | 134 | 9 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-09 | 196 | 134 | 9 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-09 | 196 | 134 | 9 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-09 | 196 | 134 | 9 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.96e-09 | 197 | 134 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.96e-09 | 197 | 134 | 9 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.96e-09 | 197 | 134 | 9 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-09 | 197 | 134 | 9 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-09 | 197 | 134 | 9 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.96e-09 | 197 | 134 | 9 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-09 | 197 | 134 | 9 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.96e-09 | 197 | 134 | 9 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.96e-09 | 197 | 134 | 9 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.96e-09 | 197 | 134 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.96e-09 | 197 | 134 | 9 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.96e-09 | 197 | 134 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 9.37e-09 | 198 | 134 | 9 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.79e-09 | 199 | 134 | 9 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.79e-09 | 199 | 134 | 9 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.79e-09 | 199 | 134 | 9 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.79e-09 | 199 | 134 | 9 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | distal-1-mesenchymal-Lipofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.79e-09 | 199 | 134 | 9 | a8293db3c42a8d30897858b49aae7acfc18663ba | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-08 | 200 | 134 | 9 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | 390C-Fibroblasts|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-08 | 200 | 134 | 9 | 3abe0f017fee6057ba73bd661a2bc8ec9e2bfe38 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-08 | 200 | 134 | 9 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-08 | 200 | 134 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.02e-08 | 200 | 134 | 9 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-08 | 200 | 134 | 9 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| Computational | Ovary genes. | COL3A1 COL5A2 VWF CRIM1 CCND1 LDLR TGFBR2 FBLN1 CCN1 SPON1 LRP1 LTBP1 NOTCH3 VEGFA | 5.02e-06 | 368 | 97 | 14 | MODULE_1 |
| Computational | DRG (dorsal root ganglia) genes. | COL3A1 VWF CRIM1 CCND1 LDLR TGFBR2 FBLN1 CCN1 LRP1 NGFR LTBP1 NOTCH3 VEGFA | 3.86e-05 | 384 | 97 | 13 | MODULE_2 |
| Computational | Adhesion molecules. | 3.89e-05 | 141 | 97 | 8 | MODULE_122 | |
| Computational | Trachea genes. | VWF CRIM1 GRN MUC5B CCND1 LDLR TGFBR2 FBLN1 CCN1 LRP1 LTBP1 NOTCH3 VEGFA | 8.55e-05 | 415 | 97 | 13 | MODULE_6 |
| Computational | Spinal cord (neuro-development) genes. | COL3A1 COL5A2 CRIM1 CCND1 LDLR FBLN1 FBN2 CCN1 LRP1 NGFR NOTCH3 VEGFA | 9.10e-05 | 360 | 97 | 12 | MODULE_12 |
| Computational | Metal / Ca ion binding. | 1.93e-04 | 133 | 97 | 7 | MODULE_324 | |
| Computational | Placenta genes. | COL3A1 COL5A2 VWF CRIM1 GRN SMYD5 CCND1 FBLN1 FBN2 CCN1 LRP1 LTBP1 NOTCH3 | 2.53e-04 | 463 | 97 | 13 | MODULE_38 |
| Computational | Neighborhood of PTX3 | 2.94e-04 | 36 | 97 | 4 | GNF2_PTX3 | |
| Computational | Genes in the cancer module 55. | COL3A1 COL5A2 CRIM1 SHMT1 GRN MUC5B CCND1 ITGA2B LDLR LY6D TGFBR2 FBN2 CCN1 LRP1 NGFR ALB FST VEGFA | 4.06e-04 | 832 | 97 | 18 | MODULE_55 |
| Computational | Cell line expressed genes. | COL5A2 VWF CRIM1 GRN EZH2 LDLR TGFBR2 EFEMP1 CCN1 ALB FST VEGFA | 4.90e-04 | 432 | 97 | 12 | MODULE_52 |
| Computational | Genes in the cancer module 236. | 5.27e-04 | 18 | 97 | 3 | MODULE_236 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | COL3A1 COL5A2 SHMT1 CCND1 ITGA2B LDLR FBN2 CCN1 LRP1 ALB FST VEGFA | 7.47e-04 | 453 | 97 | 12 | MODULE_24 |
| Computational | Neighborhood of TIMP2 | 7.61e-04 | 46 | 97 | 4 | GNF2_TIMP2 | |
| Computational | ECM and collagens. | 9.50e-04 | 225 | 97 | 8 | MODULE_47 | |
| Computational | Neighborhood of KISS1 | 9.67e-04 | 49 | 97 | 4 | GNF2_KISS1 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | COL3A1 COL5A2 VWF CRIM1 SHMT1 GRN MUC5B CCND1 ITGA2B LDLR LY6D FBN2 CCN1 NGFR ALB FST VEGFA | 1.19e-03 | 835 | 97 | 17 | MODULE_88 |
| Computational | Genes in the cancer module 27. | 1.33e-03 | 355 | 97 | 10 | MODULE_27 | |
| Computational | Neighborhood of CDH11 | 1.42e-03 | 25 | 97 | 3 | GNF2_CDH11 | |
| Computational | Lung genes. | COL3A1 VWF CRIM1 GRN CCND1 LDLR TGFBR2 FBLN1 CCN1 NOTCH3 VEGFA | 1.78e-03 | 434 | 97 | 11 | MODULE_5 |
| Computational | Genes in the cancer module 121. | 1.98e-03 | 99 | 97 | 5 | MODULE_121 | |
| Drug | probucol | NPC1 VLDLR LRP12 CD320 LRP1B LDLR CSF1 IL1F10 LRP1 LRP2 ALB CRAMP1 | 2.23e-10 | 162 | 134 | 12 | CID000004912 |
| Drug | LMWH | VEGFC COL3A1 LRP12 VWF LAMA1 LAMA3 LAMC1 ITGA2B ADAM12 LDLR FBLN1 CCN1 SPON1 LRP1 LRP2 PAPPA ALB FST VEGFA | 1.26e-08 | 663 | 134 | 19 | CID000000772 |
| Drug | Rgd Peptide | COL3A1 VWF LAMA3 LAMC1 GRN ITGA2B ITGB6 FBLN1 FBN2 CCN1 ADGRE1 VEGFA | 1.85e-08 | 239 | 134 | 12 | CID000104802 |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.83e-08 | 155 | 134 | 10 | 6817_DN | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 4.06e-08 | 161 | 134 | 10 | 3556_DN | |
| Drug | epicholesterol | NPC1 VLDLR LRP12 VWF CD320 FAS ADAM10 LRP1B LDLR LRP8 FANCB GLA AFP LRP1 LRP2 WFDC5 ALB | 2.11e-07 | 636 | 134 | 17 | CID000000304 |
| Drug | Cycloheximide | AKAP6 VLDLR GRN CCND1 FAS LDLR ITGB6 CSF1 CCN1 LRP2 PAPPA ALB FST VEGFA | 4.03e-07 | 446 | 134 | 14 | ctd:D003513 |
| Drug | iodide | PCSK5 VLDLR LRP12 VWF ITGA2B LDLR BRAP CD93 SNED1 AFP LRP1 NGFR LRP2 ALB VEGFA | 6.20e-07 | 534 | 134 | 15 | CID000024841 |
| Drug | monatepil | 6.95e-07 | 29 | 134 | 5 | CID000060810 | |
| Drug | ethylnylestradiol | COL3A1 VLDLR LRP12 VWF SLC34A2 GRN CCND1 FAS LRP1B LDLR LRP8 MMP25 FBLN1 CSF1 CCN1 AFP LRP1 NGFR LRP2 CCR5 ALB FST VEGFA | 1.06e-06 | 1251 | 134 | 23 | CID000003285 |
| Drug | vitamin E | VLDLR LRP12 SETX VWF CD320 LRP1B LDLR LRP8 EYS LRP1 LRP2 ALB VEGFA | 2.14e-06 | 441 | 134 | 13 | CID000002116 |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.39e-06 | 195 | 134 | 9 | 6052_UP | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.50e-06 | 196 | 134 | 9 | 3998_UP | |
| Drug | ezetimibe | 2.62e-06 | 147 | 134 | 8 | CID000150311 | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.95e-06 | 200 | 134 | 9 | 6029_UP | |
| Drug | hyaluronan | COL3A1 COL19A1 LAMA3 LAMC1 ADAM10 BRAP FBN2 IL1F10 ALB VEGFA | 3.70e-06 | 263 | 134 | 10 | CID000024759 |
| Drug | gemcitabine | 4.67e-06 | 270 | 134 | 10 | ctd:C056507 | |
| Drug | Epi Lovastatin | VLDLR LRP12 CCND1 CD320 LRP1B LDLR LRP8 LRP1 LRP2 CRAMP1 VEGFA | 5.78e-06 | 341 | 134 | 11 | CID000003962 |
| Drug | sodium linoleate | 5.94e-06 | 342 | 134 | 11 | CID000003931 | |
| Drug | YIGSR | 7.26e-06 | 79 | 134 | 6 | CID000123977 | |
| Drug | T0901317 | 8.39e-06 | 81 | 134 | 6 | CID000447912 | |
| Drug | Grgds | 9.67e-06 | 83 | 134 | 6 | CID000123811 | |
| Drug | troglitazone | VEGFC VLDLR RANBP2 DNER SLC34A2 CCND1 EZH2 FAS LDLR TGFBR2 FANCB CSF1 CCN1 LRP2 UHRF1 PAPPA ALB ADGRE1 FST MUC2 NOTCH3 VEGFA | 1.01e-05 | 1329 | 134 | 22 | ctd:C057693 |
| Drug | troglitazone | COL3A1 VLDLR LRP12 CCND1 LRP1B LDLR CSF1 IL1F10 LRP1 LRP2 ALB FST VEGFA | 1.43e-05 | 526 | 134 | 13 | CID000005591 |
| Drug | Fluorouracil | COL3A1 COL5A2 CRIM1 TMEM74 LAMA1 DNER LAMC1 CCND1 FAS ADAM10 LRP8 ANKRD36B FBLN1 CSF1 GLA CCN1 AFP SPON1 ANKRD36 ALB USH2A VEGFA | 1.51e-05 | 1364 | 134 | 22 | ctd:D005472 |
| Drug | 17-isoprogesterone | NPC1 COL3A1 VWF SHMT1 FBXO11 GRN CCND1 EZH2 LDLR SLC5A11 MMP25 FBLN1 CSF1 CCN1 AFP PAPPA LTBP1 FST NOTCH2 VEGFA | 1.69e-05 | 1170 | 134 | 20 | CID000004920 |
| Drug | Isotretinoin | NPC1 VEGFC COL3A1 COL5A2 LAMA3 SHMT1 LAMC1 CCND1 LDLR TGFBR2 SNED1 FBLN1 TSPAN6 LTBP1 ALB VEGFA | 1.95e-05 | 799 | 134 | 16 | ctd:D015474 |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.08e-05 | 195 | 134 | 8 | 4763_UP | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A | 2.16e-05 | 196 | 134 | 8 | 6602_DN | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.24e-05 | 197 | 134 | 8 | 3239_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; HL60; HT_HG-U133A | 2.32e-05 | 198 | 134 | 8 | 6145_UP | |
| Drug | isocycloheximide | NPC1 COL3A1 LRP12 LAMA1 LAMA3 LAMC1 CCND1 FAS LRP1B LDLR CD93 CSF1 IL1F10 LRP1 LRP2 ALB VEGFA | 2.39e-05 | 905 | 134 | 17 | CID000002900 |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | 2.41e-05 | 199 | 134 | 8 | 4087_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A | 2.41e-05 | 199 | 134 | 8 | 122_UP | |
| Drug | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2.67e-05 | 402 | 134 | 11 | ctd:C093973 | |
| Drug | AC1L1G72 | 3.18e-05 | 11 | 134 | 3 | CID000003553 | |
| Drug | AC1NS85P | 3.44e-05 | 2 | 134 | 2 | CID005355813 | |
| Drug | archazolid B | 4.08e-05 | 65 | 134 | 5 | ctd:C519728 | |
| Drug | 25-hydroxycholesterol | 4.61e-05 | 160 | 134 | 7 | CID000065094 | |
| Drug | thioglycolate | 4.72e-05 | 67 | 134 | 5 | CID000001133 | |
| Drug | 2f1b | 4.72e-05 | 67 | 134 | 5 | CID011963508 | |
| Drug | Prednisolone | 4.80e-05 | 161 | 134 | 7 | ctd:D011239 | |
| Drug | imatinib | 4.93e-05 | 430 | 134 | 11 | CID000005291 | |
| Drug | Perindopril | 5.21e-05 | 35 | 134 | 4 | ctd:D020913 | |
| Drug | AC1L1H1Q | 6.05e-05 | 167 | 134 | 7 | CID000003937 | |
| Drug | Cholesterol | 6.51e-05 | 229 | 134 | 8 | ctd:D002784 | |
| Drug | flurbiprofen | 7.03e-05 | 171 | 134 | 7 | CID000003394 | |
| Drug | Ikvav | 7.25e-05 | 38 | 134 | 4 | CID000131343 | |
| Drug | Masoprocol | 7.62e-05 | 74 | 134 | 5 | ctd:D009637 | |
| Drug | 17alpha-estradiol | VLDLR LRP12 GRN CCND1 LRP1B LDLR LRP8 MMP25 SNED1 FBLN1 CSF1 AFP LRP1 NGFR LRP2 UHRF1 PAPPA CCR5 FST VEGFA | 7.68e-05 | 1303 | 134 | 20 | CID000000450 |
| Drug | Withaferin A [5119-48-2]; Up 200; 1uM; MCF7; HT_HG-U133A | 8.42e-05 | 176 | 134 | 7 | 3902_UP | |
| Drug | canola oil | 8.59e-05 | 122 | 134 | 6 | ctd:C061996 | |
| Drug | pyrachlostrobin | COL5A2 COL19A1 LAMC1 GRN CCND1 FAS TGFBR2 EFEMP1 CSF1 CCN1 LRP2 PAPPA LTBP1 NOTCH2 NOTCH3 | 8.83e-05 | 811 | 134 | 15 | ctd:C513428 |
| Drug | 1-alpha-25-dihydroxycholecalciferol | COL3A1 PCSK5 LAMA1 DNER LAMA3 SLC34A2 LAMC1 ADAM10 ADAM28 TSPAN5 CSF1 GLA NGFR MINAR1 NUP153 VEGFA | 9.06e-05 | 909 | 134 | 16 | CID000002524 |
| Drug | AC1NAL8H | 9.81e-05 | 41 | 134 | 4 | CID004478772 | |
| Drug | lanatoside C | 1.03e-04 | 3 | 134 | 2 | CID000003879 | |
| Drug | 16-diazoestrone | 1.03e-04 | 3 | 134 | 2 | CID003080798 | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.04e-04 | 182 | 134 | 7 | 1663_DN | |
| Drug | Medroxyprogesterone Acetate | 1.05e-04 | 389 | 134 | 10 | ctd:D017258 | |
| Drug | Mifepristone | COL3A1 VLDLR VWF LAMA3 CCND1 FAS TSPAN5 FBLN1 KMT2D CSF1 SPON1 VEGFA | 1.07e-04 | 553 | 134 | 12 | ctd:D015735 |
| Drug | monoisoamyl-2,3-dimercaptosuccinate | 1.08e-04 | 42 | 134 | 4 | ctd:C091888 | |
| Drug | fenoxycarb | 1.11e-04 | 80 | 134 | 5 | CID000051605 | |
| Drug | clotrimazole; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.15e-04 | 185 | 134 | 7 | 905_UP | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 1.23e-04 | 187 | 134 | 7 | 448_DN | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.23e-04 | 187 | 134 | 7 | 5258_UP | |
| Drug | 5-FU | NPC1 COL3A1 TMEM74 DNER FAS LRP8 TGFBR2 FBLN1 CSF1 IL1F10 AFP VEGFA | 1.25e-04 | 562 | 134 | 12 | CID000003385 |
| Drug | pyrazolanthrone | 1.26e-04 | 322 | 134 | 9 | ctd:C432165 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 1.30e-04 | 44 | 134 | 4 | ctd:C419410 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.32e-04 | 83 | 134 | 5 | CID011968896 | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.36e-04 | 190 | 134 | 7 | 7145_UP | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.36e-04 | 190 | 134 | 7 | 2911_UP | |
| Drug | zoledronic acid | VWF ABCA12 LAMA1 DNER LAMA3 SLC34A2 CCND1 FAS LDLR ADAM28 FEM1B FBLN1 TENM4 CSF1 CCN1 RNFT2 UHRF1 PAPPA WFDC5 NOTCH3 VEGFA | 1.40e-04 | 1472 | 134 | 21 | ctd:C088658 |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.40e-04 | 191 | 134 | 7 | 3823_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 3667_DN | |
| Drug | Capsaicin | 1.51e-04 | 488 | 134 | 11 | ctd:D002211 | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 1.54e-04 | 194 | 134 | 7 | 7493_UP | |
| Drug | sodium cholate | 1.55e-04 | 408 | 134 | 10 | CID000000303 | |
| Drug | 5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA | 1.59e-04 | 195 | 134 | 7 | 828_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 134 | 7 | 2225_UP | |
| Drug | Arecoline hydrobromide [300-08-3]; Down 200; 17uM; HL60; HT_HG-U133A | 1.59e-04 | 195 | 134 | 7 | 1303_DN | |
| Drug | Cacodylic Acid | 1.61e-04 | 261 | 134 | 8 | ctd:D002101 | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 5253_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 4423_DN | |
| Drug | F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 6396_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 3233_DN | |
| Drug | Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 5861_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 4733_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 2301_UP | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 6633_UP | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 3875_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 4556_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; HL60; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 1317_DN | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 5611_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 4727_UP | |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 6633_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HG-U133A | 1.70e-04 | 197 | 134 | 7 | 121_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 3769_DN | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 4084_DN | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 4800_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 4358_UP | |
| Disease | Malignant neoplasm of breast | AKAP6 VEGFC VWF COL19A1 SHMT1 PHF7 CCND1 TECTA EZH2 ADAM12 ADAM10 KMT2D EFEMP1 CSF1 PRICKLE3 OTOGL AFP POP1 DHX32 CLUL1 FST NOTCH2 NOTCH3 | 2.71e-10 | 1074 | 129 | 23 | C0006142 |
| Disease | Mammary Neoplasms | VEGFC SHMT1 CCND1 EZH2 ADAM10 TGFBR2 KMT2D EFEMP1 CSF1 AFP CLUL1 FST NOTCH2 NOTCH3 | 8.45e-08 | 527 | 129 | 14 | C1458155 |
| Disease | Alzheimer's disease (is_implicated_in) | 1.25e-07 | 132 | 129 | 8 | DOID:10652 (is_implicated_in) | |
| Disease | Schizophrenia | COL3A1 VLDLR LAMA1 SHMT1 GRN CCND1 FAS ADAM12 BRAP LRP8 TENM4 LMX1A LRP1 NGFR LRP2 CCR5 BRD1 | 3.27e-07 | 883 | 129 | 17 | C0036341 |
| Disease | multiple myeloma (is_marker_for) | 5.00e-07 | 36 | 129 | 5 | DOID:9538 (is_marker_for) | |
| Disease | Prostatic Neoplasms | LMTK2 LAMC1 CCND1 EZH2 LRP1B ADAM28 TGFBR2 FBLN1 KMT2D BRPF1 NGFR LRP2 PDS5A VEGFA | 5.56e-07 | 616 | 129 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | LMTK2 LAMC1 CCND1 EZH2 LRP1B ADAM28 TGFBR2 FBLN1 KMT2D BRPF1 NGFR LRP2 PDS5A VEGFA | 5.56e-07 | 616 | 129 | 14 | C0376358 |
| Disease | Mammary Carcinoma, Human | VEGFC SHMT1 CCND1 EZH2 ADAM10 KMT2D EFEMP1 CSF1 AFP CLUL1 FST NOTCH2 NOTCH3 | 5.56e-07 | 525 | 129 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | VEGFC SHMT1 CCND1 EZH2 ADAM10 KMT2D EFEMP1 CSF1 AFP CLUL1 FST NOTCH2 NOTCH3 | 5.56e-07 | 525 | 129 | 13 | C1257931 |
| Disease | Breast Carcinoma | VEGFC SHMT1 CCND1 EZH2 ADAM10 KMT2D EFEMP1 CSF1 AFP CLUL1 FST NOTCH2 NOTCH3 | 7.31e-07 | 538 | 129 | 13 | C0678222 |
| Disease | Liver Cirrhosis, Experimental | COL3A1 ATRN COL5A2 VWF GRN ITGA2B FAS ITGB6 TGFBR2 AFP LTBP1 ALB ADGRE1 SP140 VEGFA | 1.57e-06 | 774 | 129 | 15 | C0023893 |
| Disease | amino acid measurement | VWC2 FAT4 SETX VWF LRRN1 ABCA12 ADAM12 ADAM28 MMP25 TENM4 SLIT1 LRP2 LTBP1 MUC2 | 1.72e-06 | 678 | 129 | 14 | EFO_0005134 |
| Disease | Colorectal Carcinoma | AKAP6 COL3A1 ABCA12 LAMA1 LAMC1 CCND1 CD93 TGFBR2 FBN2 EFEMP1 TRIM28 CCDC62 LRP1 LRP2 | 2.57e-06 | 702 | 129 | 14 | C0009402 |
| Disease | pulse pressure measurement | NPC1 CRIM1 TMEM74 ANKRD36C FAS TSPAN5 SLC5A11 CEP68 FBN2 EFEMP1 TENM4 FAM193A CCN1 DPF3 SLIT1 LRP1 UHRF1 LTBP1 BRD1 NOTCH3 | 2.71e-06 | 1392 | 129 | 20 | EFO_0005763 |
| Disease | Stage IV Skin Melanoma | 2.82e-06 | 7 | 129 | 3 | C1321872 | |
| Disease | Squamous cell carcinoma of esophagus | 3.93e-06 | 95 | 129 | 6 | C0279626 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.31e-06 | 55 | 129 | 5 | C0079744 | |
| Disease | Nephritis | 6.73e-06 | 9 | 129 | 3 | C0027697 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 7.46e-06 | 301 | 129 | 9 | DOID:684 (is_marker_for) | |
| Disease | Cerebrovascular accident | 7.83e-06 | 62 | 129 | 5 | C0038454 | |
| Disease | intraocular pressure measurement | VEGFC PCSK5 LRP12 ADAM12 BRAP FBN2 EFEMP1 ANAPC1 DPF3 LTBP1 FST | 1.54e-05 | 509 | 129 | 11 | EFO_0004695 |
| Disease | dementia (is_implicated_in) | 1.74e-05 | 12 | 129 | 3 | DOID:1307 (is_implicated_in) | |
| Disease | renal cell carcinoma (is_marker_for) | 2.18e-05 | 128 | 129 | 6 | DOID:4450 (is_marker_for) | |
| Disease | Migraine Disorders | 2.26e-05 | 13 | 129 | 3 | C0149931 | |
| Disease | Lung Neoplasms | 2.27e-05 | 265 | 129 | 8 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.34e-05 | 266 | 129 | 8 | C0242379 | |
| Disease | atrial fibrillation | 3.88e-05 | 371 | 129 | 9 | EFO_0000275 | |
| Disease | multiple sclerosis (is_marker_for) | 6.34e-05 | 49 | 129 | 4 | DOID:2377 (is_marker_for) | |
| Disease | Hemangiosarcoma | 6.35e-05 | 18 | 129 | 3 | C0018923 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.65e-05 | 53 | 129 | 4 | C4707243 | |
| Disease | Liver Cirrhosis | 9.18e-05 | 103 | 129 | 5 | C0023890 | |
| Disease | Fibrosis, Liver | 1.01e-04 | 105 | 129 | 5 | C0239946 | |
| Disease | von Willebrand's disease 1 (is_implicated_in) | 1.13e-04 | 4 | 129 | 2 | DOID:0060573 (is_implicated_in) | |
| Disease | Ischemic stroke | 1.13e-04 | 4 | 129 | 2 | C0948008 | |
| Disease | Atherosclerosis | 1.32e-04 | 59 | 129 | 4 | C0004153 | |
| Disease | Atherogenesis | 1.32e-04 | 59 | 129 | 4 | C1563937 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.50e-04 | 61 | 129 | 4 | DOID:3587 (is_marker_for) | |
| Disease | Liver Failure, Acute | 1.54e-04 | 24 | 129 | 3 | C0162557 | |
| Disease | Carcinoma, Granular Cell | 1.61e-04 | 116 | 129 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.61e-04 | 116 | 129 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.61e-04 | 116 | 129 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.61e-04 | 116 | 129 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.61e-04 | 116 | 129 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 1.61e-04 | 116 | 129 | 5 | C0001418 | |
| Disease | primary biliary cholangitis (is_marker_for) | 1.75e-04 | 25 | 129 | 3 | DOID:12236 (is_marker_for) | |
| Disease | Jaw Abnormalities | 1.88e-04 | 5 | 129 | 2 | C0022360 | |
| Disease | sugar consumption measurement | 1.88e-04 | 120 | 129 | 5 | EFO_0010158 | |
| Disease | Squamous cell carcinoma | 2.19e-04 | 124 | 129 | 5 | C0007137 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.47e-04 | 28 | 129 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | hepatitis C (is_implicated_in) | 2.47e-04 | 28 | 129 | 3 | DOID:1883 (is_implicated_in) | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.56e-04 | 70 | 129 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 2.56e-04 | 70 | 129 | 4 | C3241937 | |
| Disease | allergic contact dermatitis (biomarker_via_orthology) | 2.81e-04 | 6 | 129 | 2 | DOID:3042 (biomarker_via_orthology) | |
| Disease | Liver diseases | 2.85e-04 | 72 | 129 | 4 | C0023895 | |
| Disease | Liver Dysfunction | 2.85e-04 | 72 | 129 | 4 | C0086565 | |
| Disease | pentachlorophenol measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 3.00e-04 | 73 | 129 | 4 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 3.17e-04 | 74 | 129 | 4 | EFO_0007886 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.72e-04 | 139 | 129 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 3.93e-04 | 7 | 129 | 2 | C1846545 | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 3.93e-04 | 7 | 129 | 2 | C0399367 | |
| Disease | Loeys-Dietz Syndrome | 3.93e-04 | 7 | 129 | 2 | C2697932 | |
| Disease | Solid Neoplasm | 3.93e-04 | 7 | 129 | 2 | C0280100 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 3.93e-04 | 7 | 129 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 3.93e-04 | 7 | 129 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Brain Tumor, Primary | 4.05e-04 | 33 | 129 | 3 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 4.05e-04 | 33 | 129 | 3 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 4.05e-04 | 33 | 129 | 3 | C0750977 | |
| Disease | Benign neoplasm of brain, unspecified | 4.05e-04 | 33 | 129 | 3 | C0496899 | |
| Disease | Neoplasms, Intracranial | 4.05e-04 | 33 | 129 | 3 | C1527390 | |
| Disease | Behcet's disease (is_marker_for) | 4.05e-04 | 33 | 129 | 3 | DOID:13241 (is_marker_for) | |
| Disease | central corneal thickness | 4.34e-04 | 309 | 129 | 7 | EFO_0005213 | |
| Disease | cervical cancer | 4.42e-04 | 34 | 129 | 3 | C4048328 | |
| Disease | leptin measurement | 4.47e-04 | 81 | 129 | 4 | EFO_0005000 | |
| Disease | liver cirrhosis (is_marker_for) | 4.68e-04 | 82 | 129 | 4 | DOID:5082 (is_marker_for) | |
| Disease | Uterine Cervical Neoplasm | 4.82e-04 | 35 | 129 | 3 | C0007873 | |
| Disease | Nerve Degeneration | 4.91e-04 | 83 | 129 | 4 | C0027746 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 5.13e-04 | 84 | 129 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | Urologic Neoplasms | 5.22e-04 | 8 | 129 | 2 | C0042076 | |
| Disease | bipolar II disorder | 5.22e-04 | 8 | 129 | 2 | EFO_0009964 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CASDVSKCLIQELCQ | 31 | Q9GZX9 | |
| CQTPEPVEENKCFEC | 306 | Q7Z569 | |
| EQQSLIDEDAVCCIC | 206 | O95696 | |
| MADCCAKQEPERNEC | 111 | P02768 | |
| CANVSTREECNCTKD | 911 | Q9H7T0 | |
| ERSEISCCQKNEACL | 491 | Q6P9F0 | |
| ESLVQCVKTFCCQLE | 621 | Q76N32 | |
| CGDNKVCINAECVDI | 606 | Q9UKQ2 | |
| SDQCKDECCFDANQP | 476 | O14672 | |
| VCSCSENVQECPKFN | 1846 | Q86UK0 | |
| ESFQPNCKHQCTCID | 111 | O00622 | |
| CCPQDTVCDLIQSKC | 246 | P28799 | |
| ACERDINECLQSPCK | 3896 | Q6V0I7 | |
| VDECQDSPCAQECVN | 346 | Q9NPY3 | |
| CNATTCTLKPDAVCA | 451 | O43184 | |
| MCNLDCQEEPDSCIS | 51 | P06280 | |
| KCQCSESTCIMNPEV | 336 | Q8TC27 | |
| CACQEVQTTKLPSSC | 666 | Q17RM4 | |
| VIKCDPDCLRACQEQ | 236 | P24385 | |
| QTVSEDGDSLCCNCK | 1336 | A6QL64 | |
| VSEDGDSLCCNCKNV | 776 | Q8N2N9 | |
| CKCCSIFQQEAPERA | 321 | P51681 | |
| EQQMCETCPETEQRC | 726 | Q7L7V1 | |
| APNTCECHVCKQEAS | 406 | P78312 | |
| QESICTQEEGDCCPT | 5501 | Q9HC84 | |
| RNEASATKCIACQCP | 1736 | P49792 | |
| CVQNESSSLKCVACD | 1791 | P49792 | |
| LISPTCSCKQADICV | 576 | Q29RF7 | |
| EVEKCICILQSSCIN | 146 | Q9H1A4 | |
| VSEDGDSLCCNCKNV | 1201 | Q5JPF3 | |
| PKATPVSETCDCQCE | 521 | Q9NPA2 | |
| CQTDMNECLSEPCKN | 946 | Q04721 | |
| DPVADNCCAEKICIL | 31 | Q8WWZ1 | |
| DETNCTMCQKEEFPC | 406 | Q9Y561 | |
| CSDNSDEENCKPQTC | 3501 | Q9NZR2 | |
| ECSSEPCKNNGTCVD | 931 | Q5T1H1 | |
| CKENVEGTECNVCRE | 1426 | Q16787 | |
| CKSCILCGTSENDDQ | 316 | Q92784 | |
| AACPESCVVCTKDVT | 6 | A6NM62 | |
| EKDCTPRCDMDQFQC | 3606 | Q07954 | |
| EEECRIEPCTQKGQC | 86 | Q9NPF0 | |
| CINQSICEKCENLTT | 1071 | O75882 | |
| VCISTKTQCSEEDQC | 451 | Q9UK73 | |
| DSSCPCVIAQNFCEK | 531 | Q15910 | |
| SCAKCQGPTQEDCTT | 891 | Q92824 | |
| PPSAQECCDCQDTTD | 1711 | Q92824 | |
| LLVSPECNCDCQKEV | 446 | P18564 | |
| ECNCDCQKEVEVNSS | 451 | P18564 | |
| HEQCVQCASCKEPLE | 56 | Q8TE12 | |
| CLDVDECLEPNVCAN | 1036 | Q14766 | |
| TCEDIDECVNNTVCD | 1241 | Q14766 | |
| TPGQEITNDCEQCVC | 361 | Q02817 | |
| SVPTEETCKSCVCTN | 1201 | Q02817 | |
| CVCTNSSQVVCRPEE | 1211 | Q02817 | |
| TEVNPADTCCNITVC | 4871 | Q02817 | |
| DPCCQICNSVALEIQ | 101 | Q6ZU69 | |
| CTEDVDECQLQPNAC | 271 | Q9UM47 | |
| CEVDIDECQSSPCVN | 466 | Q9UM47 | |
| LIANCVSCCKDPEID | 61 | Q8IWU2 | |
| CTEMPFVCSQKCENV | 3156 | P98164 | |
| KERTCAENICEQNCT | 3966 | P98164 | |
| PNCIPCKETCENVDC | 86 | P19883 | |
| GECCDPEITNVTQTC | 471 | Q13219 | |
| LPDSCCQACKDEASE | 166 | Q6WN34 | |
| EQATCPNCRCEISKS | 106 | Q6ZMK1 | |
| DTCKNLRACCIPSNE | 46 | Q96PH6 | |
| CTSCMCVKDQEAQEP | 336 | Q9Y2T5 | |
| LKECCLSEEECTQEP | 186 | Q8NB91 | |
| VDEVTAPCSCQDCSI | 231 | O15118 | |
| ACQCVEPIKSAVCIA | 346 | Q99575 | |
| CQACDEIIFSPECTE | 251 | O43900 | |
| CKQQCRDTGDEVVCS | 186 | P23142 | |
| CQDTAGNCPEKECSL | 106 | Q96QU4 | |
| CQDTAGNCPEKECSL | 106 | Q64ET8 | |
| AECSSQDVVTKPDCN | 176 | P09603 | |
| TCCEISDTKCPEQDG | 241 | Q14993 | |
| ACPTIKHCNISDCEN | 396 | Q86XK2 | |
| KSCQDLIVPEQCRCA | 566 | Q96RY5 | |
| KCCDVFECVNDTKPA | 321 | Q9NZV1 | |
| CQCINTEELCSERKQ | 496 | Q9NZV1 | |
| CDKIECQDVLDCADP | 71 | P05997 | |
| TSSTQCCQEDLCNEK | 81 | Q14210 | |
| CNIETGRCVCKDNVE | 456 | P11047 | |
| QICVCDSGSVLCDDI | 51 | P02461 | |
| CTDVDECQTPGICMN | 656 | P35556 | |
| TCSDVDECAENINLC | 1446 | P35556 | |
| ACEEKVDPCASSPCQ | 426 | Q8NFT8 | |
| QTLAKECVAQGCCVD | 681 | P53992 | |
| KCCQGQEQEVCFAEE | 581 | P02771 | |
| DIDECKDPDACSQIC | 376 | Q14114 | |
| SIQNSECPQLCVCEI | 26 | Q6UXK5 | |
| AQCIPEKECACTDSE | 1856 | Q3ZCN5 | |
| TEICNAAECEPLNCE | 126 | Q9UPX6 | |
| VLEACSIACNKNTCP | 376 | P34896 | |
| IDVDDCADSPCCQQV | 371 | O75095 | |
| QCKDIDECDIVPDAC | 41 | Q12805 | |
| EPESSSCNCIQCELK | 1136 | Q5JY77 | |
| SCNCIQCELKIGSEE | 1141 | Q5JY77 | |
| QCTEAGDICAICQAE | 376 | Q96EX2 | |
| DVCKPCDCDTVGTRN | 636 | O75445 | |
| EKCTVNEECSPSSCL | 546 | Q9HCB6 | |
| VAECLQQETTCPVCL | 6 | P14373 | |
| LQSCSECILAQDPVC | 516 | O95754 | |
| GEESCILCCEDLSQQ | 156 | Q9BWX1 | |
| CVEETGACPCKENVF | 1111 | P25391 | |
| STCQSKCDDPEEELC | 2616 | Q7Z333 | |
| CSITSICEKPQEVCV | 71 | P37173 | |
| DQVACADPEICQKIC | 336 | Q8WWX8 | |
| CDSAPCTVVQCDLQE | 911 | P08514 | |
| CETAQSPCDTKECQH | 346 | Q8TER0 | |
| PNALVDEDAVCCICN | 266 | P55201 | |
| ASISNISCCNCEPDV | 2031 | Q13023 | |
| ISCCNCEPDVFHQKD | 2036 | Q13023 | |
| DIDECTEMCPINSTC | 221 | Q14246 | |
| KCQKCQAHLSEDCPD | 321 | Q15846 | |
| CSKCCEDLEEAQEGQ | 641 | O95436 | |
| VIQCDPRQCKSDEEC | 1456 | O75443 | |
| KCVEKCPCDAETDQA | 391 | Q9H6R6 | |
| CLLSVPDQCVEDSQC | 41 | Q8TCV5 | |
| SDIDCPQTDKCCESR | 171 | Q8IUA0 | |
| CCVEFCQSKATGEEI | 206 | O94967 | |
| EVLCTVSACPQTECV | 246 | Q2TAL6 | |
| GPNKELDEETCQCVC | 281 | P49767 | |
| ELEETAARCVCPFCQ | 131 | Q96EQ8 | |
| DVQDQCSCCSPTRTE | 2766 | P04275 | |
| NSTVCEHCDPCTKCE | 136 | P25445 | |
| FSCQDKQNTVCEECP | 136 | P08138 | |
| VLCVCDLSPAQCDIN | 76 | Q2MV58 | |
| CNDSKLNVCSVEEVC | 631 | Q70CQ1 | |
| EVSCEKVPCQRACAD | 716 | Q96DN2 | |
| CVTKVNPECDDQEDC | 166 | Q7Z410 | |
| CQDKCLVQAQEVCLS | 41 | Q5T870 | |
| EVCLSQCQESSQEKC | 51 | Q5T870 | |
| AECDVPTNQCIDVAC | 621 | Q6N022 | |
| SCCKLEDCTPQRDAD | 176 | O43657 | |
| DELVCVCDLENCSNI | 386 | P08922 | |
| VCCVSNNAEDNKCVS | 801 | P49790 | |
| SKVEETFQCICCQEL | 716 | Q96T88 | |
| CCTKDPAEDVINTQC | 186 | P62079 | |
| NEKCSCVMCFSEEVP | 451 | Q13342 | |
| ERKVCNCCSQELETS | 96 | Q96NL1 | |
| VQDPQTCKCSCKNTD | 196 | P15692 | |
| QECACLDTVVRCSNK | 736 | O75093 | |
| CSCPKCLAEADEPNV | 376 | Q6GMV2 | |
| LCQKVSEEVCQLCLE | 1316 | Q6PFW1 | |
| SCLCLEENVENDPCK | 2221 | O75962 | |
| DCPVCKQQCFSKDIV | 116 | Q13263 | |
| CIDISKVCNQEQDCR | 331 | P98155 | |
| ECIVCEVCGQASDPS | 1426 | O14686 | |
| SCAPNCVAEVVTFDK | 5476 | O14686 | |
| DECQDPDTCSQLCVN | 356 | P01130 |